Original Article
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
N Engl J Med 1998; 338:409-416February 12, 1998
- Abstract
Background
The efficacy and safety of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis are still a matter of debate.
Methods
Using a two-by-two factorial design, we randomly assigned 400 patients with proximal deep-vein thrombosis who were at risk for pulmonary embolism to receive a vena caval filter (200 patients) or no filter (200 patients), and to receive low-molecular-weight heparin (enoxaparin, 195 patients) or unfractionated heparin (205 patients). The rates of recurrent venous thromboembolism, death, and major bleeding were analyzed at day 12 and at two years.
Results
At day 12, two patients assigned to receive filters (1.1 percent), as compared with nine patients assigned to receive no filters (4.8 percent), had had symptomatic or asymptomatic pulmonary embolism (odds ratio, 0.22; 95 percent confidence interval, 0.05 to 0.90). At two years, 37 patients assigned to the filter group (20.8 percent), as compared with 21 patients assigned to the no-filter group (11.6 percent), had had recurrent deep-vein thrombosis (odds ratio, 1.87; 95 percent confidence interval, 1.10 to 3.20). There were no significant differences in mortality or the other outcomes. At day 12, three patients assigned to low-molecular-weight heparin (1.6 percent), as compared with eight patients assigned to unfractionated heparin (4.2 percent), had had symptomatic or asymptomatic pulmonary embolism (odds ratio, 0.38; 95 percent confidence interval, 0.10 to 1.38).
Conclusions
In high-risk patients with proximal deep-vein thrombosis, the initial beneficial effect of vena caval filters for the prevention of pulmonary embolism was counterbalanced by an excess of recurrent deep-vein thrombosis, without any difference in mortality. Our data also confirmed that low-molecular-weight heparin was as effective and safe as unfractionated heparin for the prevention of pulmonary embolism.
Media in This Article
Table 1
Base-Line Characteristics of the Study Patients.Table 2
Principal End Points within the First 12 Days after Randomization to the Filter or No-Filter Group.Article Activity
- Article
Placing a barrier in the inferior vena cava to prevent pulmonary embolism arising from venous thrombi was first suggested by Trousseau in 1868.1 The procedure became common after intracaval filters became available in the late 1960s.2 However, unfractionated heparin followed by oral anticoagulants for three months prevents pulmonary embolism in 95 percent of patients with proximal deep-vein thrombosis.3,4 In these patients, the generally accepted indications for filter placement are therefore restricted to contraindications to or failures of anticoagulant therapy.5-7
The ease of insertion of the new filters by the percutaneous route and the reportedly low complication rates have increased their use and probably widened the indications for their use.8-10 According to industry sources, 30,000 to 40,000 filters are inserted each year in the United States.10 Among patients who have received filters and anticoagulants,5 between 10 and 50 percent have presented with acute deep-vein thrombosis and concomitant pulmonary embolism,11 chronic cardiac or pulmonary insufficiency,12,13 advanced age,14 cancer,15 or large proximal16 or free-floating16,17 thrombi. Evidence supporting the effectiveness of filters is lacking because there have been no randomized trials.5,18,19 We undertook a randomized trial to evaluate the benefits and risks of prophylactic filter placement in addition to anticoagulant therapy in patients with proximal deep-vein thrombosis who were considered to be at high risk for pulmonary embolism.
Low-molecular-weight heparins have been shown to be at least as effective and safe as unfractionated heparin in the treatment of deep-vein thrombosis.4 There was a need to evaluate these compounds in patients presumed to be at high risk who might receive a vena caval filter for prophylactic purposes. A two-by-two factorial design allowed us to compare both the use of a filter with no filter and low-molecular-weight heparin with unfractionated heparin.
Methods
Study Design
In a multicenter, randomized, open trial at 44 centers in France, we compared the installation of a permanent vena caval filter with no filter and fixed-dose subcutaneous low-molecular-weight heparin with adjusted-dose intravenous unfractionated heparin. The protocol was approved by the institutional review boards of all participating institutions.
Patients
Consecutive hospitalized patients over 18 years of age were eligible if they had acute proximal deep-vein thrombosis confirmed by venography, with or without concomitant symptomatic pulmonary embolism, and if their physicians considered them to be at high risk for pulmonary embolism. Patients were excluded if they had any of the following: placement of a previous filter, contraindication to or failure of anticoagulant therapy, curative anticoagulant therapy lasting more than 48 hours, an indication for thrombolysis, short life expectancy, allergy to iodine, hereditary thrombophilia, severe renal or hepatic failure, pregnancy, or likelihood of noncompliance. After the patients gave written informed consent, randomization (stratified according to center) was performed by means of a central 24-hour computer telephone system.
Treatments
Four types of permanent vena caval filters were used: Vena Tech LGM (B. Braun, Boulogne, France), titanium Greenfield (Boston Scientific, Watertown, Mass.), Cardial (Bard, Saint-Etienne, France), and Bird's Nest (Cook Group, Bloomington, Ind.). These percutaneous filters were inserted under fluoroscopic control through a femoral or jugular vein immediately after the patient was randomized and cavography was performed.
Patients assigned to unfractionated heparin (Fournier, Paris) received an intravenous bolus dose of 5000 IU, then a continuous intravenous infusion of 500 IU per kilogram of body weight per day for 8 to 12 days, adjusted according to the activated partial-thromboplastin time so that the ratio of the patient's value to the control value remained between 1.5 and 2.5, according to the reagent used. Tests were performed four to six hours after the beginning of treatment or after a subtherapeutic activated partial-thromboplastin time had been recorded, and then at least daily. Patients assigned to low-molecular-weight heparin were given a weight-adjusted dose (1 mg, or 100 International Factor Xa Inhibitory Units, per kilogram) of subcutaneous enoxaparin (Bellon Rhône–Poulenc Rorer, Montrouge, France) every 12 hours for 8 to 12 days.
Warfarin or acenocoumarol therapy was started on day 4 and continued for at least three months. The dose was adjusted to achieve an international normalized ratio of 2 to 3. Treatment with either unfractionated heparin or low-molecular-weight heparin was continued until the international normalized ratio was 2 or more for two consecutive days. If the use of an oral anticoagulant was not possible, subcutaneous unfractionated heparin was used (ratio of activated partial-thromboplastin time to control value, 1.5 to 2) for at least three months. Graded-compression stockings were prescribed for the same period.
Base-Line Evaluation of Pulmonary Perfusion
All patients underwent base-line ventilation–perfusion scanning within 48 hours of enrollment. Pulmonary angiography was performed if the ventilation–perfusion scan was not available and was strongly recommended if the ventilation–perfusion scan was abnormal. A diagnosis of initial pulmonary embolism was made if there were positive findings on pulmonary angiography (intraluminal filling defect or sudden arterial cutoff ) or, when pulmonary angiography was unavailable, if a ventilation–perfusion scan showed a high probability of pulmonary embolism.20
Follow-up and Surveillance
When clinically suspected pulmonary embolism occurred during the first 12 days, a ventilation–perfusion scan was obtained. Pulmonary angiography was performed if the ventilation–perfusion scan showed that the patient's condition was becoming worse (at least one new segmental perfusion defect) or if a scan could not be obtained. The same procedure was systematically performed between days 8 and 12 in all patients in whom pulmonary embolism was not confirmed before that date, in order to detect asymptomatic embolism. During initial treatment, full blood counts were obtained at base line, then twice weekly and when there was any bleeding.
At discharge, all patients and their general practitioners were asked to report any new symptoms of recurrent venous thromboembolism or any bleeding to the investigating center immediately. Follow-up visits were scheduled at three months and one year. At two years, the patient received a telephone call from a physician from the coordinating center who was unaware of the treatment assignments. During each visit or telephone call, the patient was asked about new symptoms of thromboembolic or hemorrhagic events and was asked to come to the investigating center again if such symptoms developed. For all events, radiologic, biologic, and clinical data, obtained at the time of occurrence, were recorded centrally by the coordinating center.
Assessment of Outcome Events
The primary outcome event was the occurrence of pulmonary embolism, either symptomatic or asymptomatic, within the first 12 days after randomization. Diagnosis of pulmonary embolism was based on a comparison between the base-line findings and those obtained when pulmonary embolism was suspected or between days 8 and 12. The angiographic diagnosis required the visualization of a new intraluminal filling defect or a sudden new arterial cutoff. When pulmonary angiography was unavailable, the diagnosis based on the ventilation–perfusion scan required the visualization of at least two new segmental mismatched perfusion defects, with no current improvement in other areas in cases of initial extensive perfusion defects.21,22 Symptomatic pulmonary embolism included fatal pulmonary embolism diagnosed on the basis of strong clinical evidence or at autopsy.
Secondary outcome events were all symptomatic and included pulmonary embolism, recurrent deep-vein thrombosis, death, major filter complications, and major bleeding during the two-year follow-up period. Diagnosis of recurrent venous thromboembolism was based on a comparison between the previous findings and those obtained when thromboembolism was suspected. The diagnostic procedures for pulmonary embolism were identical to those for the primary outcome event. Recurrence of deep-vein thrombosis was diagnosed if there was a new intraluminal filling defect on venography or if there was a lack of compressibility at a new site or an extension to a new venous segment of the thrombus on duplex ultrasonography.23,24 In suspected venous thromboembolism, patency of the filter had to be assessed by duplex ultrasonography, cavography, or abdominal computed tomography. Major filter complications included thrombosis at the filter site, erosion into the wall of the vena cava, infection, and migration of the filter. Major bleeding was defined as overt hemorrhage that was fatal or that required transfusion of at least two units of red cells, surgical intervention, or cessation of treatment.
All pulmonary investigations performed within the first 12 days and all documented symptomatic events, including deaths, were validated by an independent adjudication committee whose members were unaware of the treatment assignments.
Statistical Analysis
The incidence of symptomatic pulmonary embolism in patients with proximal deep-vein thrombosis who were treated with intravenous unfractionated heparin alone was estimated to be about 1 to 2 percent during the first 12 days of treatment.25,26 Since we decided to study a population presumably at high risk and also to consider both symptomatic and asymptomatic pulmonary embolism, we estimated that this incidence would be about 5 percent in the no-filter group and 1 percent in the filter group.5 A reduction in the incidence of pulmonary embolism from 5 to 1 percent, with a two-tailed test at an alpha level of 5 percent and a beta risk of 10 percent, would require a sample size of 400 patients per group, or a total of 800 patients. However, the study was interrupted when, after the enrollment of 400 patients over four years, the steering committee, unaware of the results, decided that the slow recruitment rate was not compatible with continuation of the study.
All analyses were performed on an intention-to-treat basis. The chi-square test, Fisher's exact test, and Student's t-test were used. For long-term end points, Kaplan–Meier analysis of the cumulative rate of events was performed. Data on patients who died or were lost to follow-up were censored. Statistical significance was assessed with the Mantel–Haenszel method. Because of the factorial design, tests for interaction were performed.27
Results
Study Population
Between September 1991 and February 1995, 400 patients were recruited. The log books, which were available from 13 centers (from which 272 patients were enrolled), recorded 735 patients who met the inclusion criteria. Of these, 370 (50 percent) were excluded, for the following reasons: placement of a previous filter (30 patients), contraindication to or failure of anticoagulant therapy (40 patients), anticoagulant therapy lasting more than 48 hours (88 patients), indication for thrombolysis (52 patients), short life expectancy (58 patients), follow-up impracticable (43 patients), and other reasons (59 patients). Of the 365 eligible patients, 93 did not consent to participate.
Of the 400 patients, 200 were randomly assigned to receive filters and 200 to receive no filters; 195 patients were randomly assigned to receive low-molecular-weight heparin and 205 to receive unfractionated heparin. The base-line characteristics of the treatment groups were similar (Table 1Table 1
Base-Line Characteristics of the Study Patients.). A total of 197 patients presented with initial pulmonary embolism (145 symptomatic and 52 asymptomatic patients), which was confirmed by angiography in 84 percent of patients and by ventilation–perfusion scanning in 16 percent of patients. Ninety percent of patients presented with at least one, and 61 percent with at least two, of the following features: initial symptomatic pulmonary embolism, chronic cardiac or respiratory insufficiency, age of more than 70 years, cancer, or iliocaval thrombosis.Treatments and Follow-up
Among the 200 patients assigned to receive a filter, 4 either refused the filter or had their filter removed because it failed. Among the 200 patients assigned to receive no filter, 8 received a filter within the first 12 days (4 in each heparin group), because of major bleeding or pulmonary embolism.
All patients received initial low-molecular-weight heparin or unfractionated heparin. Four patients assigned to receive unfractionated heparin received low-molecular-weight heparin. Ninety-four percent of the patients received the assigned heparin treatment for at least eight days. Premature discontinuation of heparin was not medically justified in two patients. At discharge, 91 percent of the patients were receiving oral anticoagulants, and 8 percent were receiving subcutaneous unfractionated heparin; 1 percent received no anticoagulants because of major bleeding. Ninety-four percent of the patients were still receiving anticoagulants at three months, and 38 percent at two years, with no significant differences between groups.
A systematic detection of asymptomatic pulmonary embolism between days 8 and 12 could not be undertaken for 28 patients: 4 who died of causes not related to pulmonary embolism before systematic investigation was undertaken, and 24 whose investigations were not performed or were not interpretable. Information about the primary outcomes for these patients was missing. At two years, the vital status of one patient was unknown, and whether nonfatal events had occurred was unknown for three patients.
Filter Compared with No Filter
Of the patients assigned to receive a filter, 56 percent received a Vena Tech LGM filter, 26.5 percent received a titanium Greenfield filter, and 15.5 percent received a Cardial or Bird's Nest filter. Two percent received no filter.
Thromboembolism
By day 12, two patients (1.1 percent) in the filter group and nine patients (4.8 percent) in the no-filter group had had symptomatic or asymptomatic pulmonary embolism (P = 0.03) (Table 2Table 2
Principal End Points within the First 12 Days after Randomization to the Filter or No-Filter Group.). The difference was still significant when the analysis was adjusted for heparin therapy. When only patients with pulmonary embolism at enrollment were considered, similar results were obtained (1.1 percent and 8.6 percent, respectively).After two years, symptomatic pulmonary embolism had occurred in 6 patients (with one death) in the filter group and in 12 patients (with five deaths) in the no-filter group (P = 0.16) (Table 3Table 3
Principal End Points during the Two-Year Follow-up Period in the Filter and No-Filter Groups.). By multivariate analysis, an initial pulmonary embolism (whether symptomatic or not) was not a significant prognostic indicator of subsequent pulmonary embolism. Recurrent deep-vein thrombosis occurred in 37 patients (20.8 percent) assigned to receive a filter and in 21 patients (11.6 percent) assigned to receive no filter (odds ratio, 1.87; 95 percent confidence interval, 1.10 to 3.20; P = 0.02) (Table 3). Recurrent venous thromboembolism occurred in 37 patients (20.8 percent) assigned to receive a filter and 29 patients (15.5 percent) assigned to receive no filter.Mortality
In the first 12 days, five patients in the filter group died (two from bleeding on days 10 and 12, one from myocardial infarction on day 1, one from respiratory failure on day 10, and one from acute renal insufficiency on day 9), and five patients in the no-filter group died (four from pulmonary embolism on days 3, 4, 6, and 7, and one from infectious disease on day 4) (Table 2). After two years, 43 patients (21.6 percent) in the filter group had died, as compared with 40 patients (20.1 percent) in the no-filter group (Table 3). The causes of death were cancer (18 patients), cardiac or respiratory failure (13 patients), infectious disease (9 patients), bleeding (9 patients), pulmonary embolism (6 patients), and other causes (28 patients). According to multivariate analysis, chronic cardiac or respiratory insufficiency, age, and cancer were significant prognostic indicators of mortality. Adjustment for these factors did not change the results of the analysis.
Major Bleeding
With respect to the occurrence of major bleeding, no significant difference between groups was observed at day 12 (Table 2) or during long-term follow-up (Table 3).
Major Symptomatic Complications in the Filter Group
Examination for filter patency was performed in the 37 patients who had symptomatic recurrent venous thromboembolism within the two-year follow-up period. The examination found a thrombosis at the filter site in 16 patients (12 with recurrent deep-vein thrombosis and 4 with concomitant pulmonary embolism and recurrent deep-vein thrombosis). No other major complications were observed.
Low-Molecular-Weight Heparin Compared with Unfractionated Heparin
Thromboembolism
By day 12, three patients in the low-molecular-weight–heparin group (1.6 percent) and eight patients in the unfractionated-heparin group (4.2 percent) had had symptomatic or asymptomatic pulmonary embolism (P = 0.14) (Table 4Table 4
Principal End Points within the First 12 Days after Randomization to the Low-Molecular-Weight–Heparin or Unfractionated-Heparin Group.). Analysis adjusted for filter assignment gave similar results. When only patients with pulmonary embolism at enrollment were considered, similar results were obtained (2.2 percent and 7.2 percent, respectively).At three months, recurrent venous thromboembolism had been confirmed in 10 patients (5.3 percent) assigned to low-molecular-weight heparin (3 with pulmonary embolism and 7 with recurrent deep-vein thrombosis) and in 12 patients (6.0 percent) assigned to unfractionated heparin (4 with pulmonary embolism, 1 with pulmonary embolism and recurrent deep-vein thrombosis, and 7 with recurrent deep-vein thrombosis). At two years no difference was observed between the two groups (Table 5Table 5
Principal End Points during the Two-Year Follow-up Period in the Low-Molecular-Weight–Heparin and Unfractionated-Heparin Groups.).Mortality
In the first 12 days, four patients in the low-molecular-weight–heparin group died (one from pulmonary embolism on day 6, one from bleeding on day 12, one from infectious disease on day 4, and one from respiratory failure on day 10), and six patients in the unfractionated-heparin group died (three from pulmonary embolism on days 3, 4, and 7, one from bleeding on day 10, one from myocardial infarction on day 1, and one from renal insufficiency on day 9) (Table 4). After two years, 20.6 percent of the patients in the low-molecular-weight–heparin group and 21.1 percent of the patients in the unfractionated-heparin group had died (Table 5).
Major Bleeding
By day 12, seven patients in the low-molecular-weight–heparin group (3.6 percent) and eight patients in the unfractionated-heparin group (3.9 percent) had had major bleeding (Table 4). After three months, major bleeding had occurred in 10 patients (with two deaths) in the low-molecular-weight–heparin group and in 11 patients (with two deaths) in the unfractionated-heparin group (Table 5).
Thrombocytopenia
Within the first 12 days, heparin-induced thrombocytopenia was observed in two patients in the low-molecular-weight–heparin group and four patients in the unfractionated-heparin group. All cases were reversible without complications after the discontinuation of heparin treatment.
Interaction between Filter and Heparin Comparisons
Of the 11 patients who had a pulmonary embolism by day 12, 1 patient among the 2 in the filter group and 2 patients among the 9 in the no-filter group had received low-molecular-weight heparin. The interaction between the filter and heparin regimens was not statistically significant for the primary or secondary outcome events.
Discussion
This study was undertaken to assess the efficacy and safety of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. We found that, in addition to heparin therapy, the use of a permanent filter initially reduced the occurrence of symptomatic or asymptomatic pulmonary embolism without major complications. However, no effect was observed on either immediate or long-term mortality. In addition, after two years, the initial beneficial effect of filters was counterbalanced by a significant increase in recurrent deep-vein thrombosis, which could be related to thrombosis at the filter site. Whatever its cause, this excess recurrence of deep-vein thrombosis should increase the incidence of the post-thrombotic syndrome and raises the question of whether long-term anticoagulant therapy should be administered after placement of a permanent filter.5,28
As compared with unfractionated heparin, low-molecular-weight heparin produced a better outcome in terms of the incidence of symptomatic or asymptomatic pulmonary embolism at day 12 and of recurrent venous thromboembolic events and mortality at three months, but the differences were not statistically significant. These results, observed in patients presumed to be at high risk, were consistent with those of a meta-analysis4 of trials comparing low-molecular-weight heparin and unfractionated heparin in the treatment of isolated deep-vein thrombosis and with those of a recent study29 comparing low-molecular-weight heparin with unfractionated heparin in the treatment of deep-vein thrombosis with or without concomitant pulmonary embolism. Although a significant reduction in major bleeding has been reported with the use of low-molecular-weight heparin,4 we observed a similar incidence of major bleeding with low-molecular-weight and unfractionated heparin. A possible explanation for this difference may be the inclusion in our study of an older population more prone to bleeding,30 whatever the treatment.
Although no significant interaction was found between the use or nonuse of a filter and the use of low-molecular-weight or unfractionated heparin, the initial beneficial effect of filters with concomitant low-molecular-weight heparin remains to be assessed.
This study demonstrated the initial efficacy of filters for the prevention of pulmonary embolism in patients presumed to be at high risk who had proximal deep-vein thrombosis and were receiving anticoagulants. However, because of the observed excess rate of recurrent deep-vein thrombosis and the absence of any effect on mortality among patients receiving filters, their systematic use cannot be recommended in this population. In addition, this study showed that low-molecular-weight heparin was as effective and safe as unfractionated heparin for the initial treatment of proximal deep-vein thrombosis in patients presumed to be at high risk.
Source Information
From the Thrombosis Research Group, Clinical Pharmacology Unit (H.D., S.L.), Intensive Care Unit (Y.P., B.T.), and Department of Radiology (F.-G.B.), Bellevue Hospital, Saint-Etienne; the Clinical Pharmacology Unit, Cardiological Hospital, Lyons (A.L.); the Respiratory Unit, Antoine Béclère Hospital, Clamart (F.P., G.S.); the Institut Mutualiste Montsouris, Paris (P.G.); the Cardiology Unit, Clinique Saint-Vincent, Besançon (R.F.); the Cardiology Unit, Trousseau Hospital, Tours (B.C.); and Rhône–Poulenc Rorer, Paris (Y.H.) — all in France.
Address reprint requests to Dr. Decousus at the Thrombosis Research Group, Clinical Pharmacology Unit, Hôpital Bellevue, CHU Saint-Etienne, 42055 Saint-Etienne CEDEX 2, France.
The investigators and institutions participating in the study are listed in the Appendix.
Appendix
The members of the Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group were as follows (all in France): Participating Centers (in order of the number of patients enrolled): Bellevue Hospital, Saint-Etienne: Y. Page, B. Tardy, P. Mismetti, I. Cusey, C. Comtet, and J.C. Bertrand; Antoine Béclère Hospital, Clamart: F. Parent, G. Simonneau, and D. Musset; Clinique St. Vincent, Besançon: R. Faivre and P.Y. Petiteau; Trousseau Hospital, Tours: G. Pacouret and B. Charbonnier; General Hospital, Firminy: P. Sagnol and P. Mathern; Laënnec Hospital, Paris: G. Meyer and H. Sors; Cavale Blanche Hospital, Brest: L. Bressolette and D. Mottier; General Hospital, Roanne: P. Mottet and G. Tempelhoff; Hôtel Dieu Hospital, Angers: A. Furber and P. Geslin; Lariboisière Hospital, Paris: G. Simoneau, P. Molho-Sabatier, and J.F. Bergmann; General Hospital Lucien Hussel, Vienne: C. Poulain and B. Veyre; Belle-Isle Hospital, Metz: J. Hermann and H. Joffreau; Nord Hospital, Marseilles: C. Juhan and Y. Alimi; Clinique St. Hilaire, Agen: R. Constans and J.L. Leymarie; Fleyriat Hospital, Bourg en Bresse: G. Demingeon and L. Holzapfel; Côte de Nacre Hospital, Caen: O. Coffin; Clinique du Mail, La Rochelle: J.P. Marcadé and J.P. Chantereau; Pasteur Hospital, Nice: F. Lemoigne; St. Joseph Hospital, Paris: P. Priollet, I. Lazareth, and G. Farkas; Germon et Gauthier Hospital, Béthune: B. D'Hautefeuille, C. Mycinski, and A. Senoussi; Lyon Sud Hospital, Lyons: C. Guerin; Hôtel Dieu Hospital, Rennes: B. Schleich and A. Le Helloco; General Hospital, Albi: M. Ammor and D. Galley; General Hospital, Allauch: M. Escande and B. Diadema; General Hospital, Annecy: J.B. Driancourt and P. Achard; General Hospital, Bourgoin-Jailleux: A. Pinel; General Hospital Louis Pasteur, Dole: F. Apffel and D. Magnin; La Tronche Hospital, Grenoble: P. Carpentier; General Hospital, Le Mans: D. Fagart; Dupuytren Hospital, Limoges: P. Lacroix; Broussais Hospital, Paris: J. Emmerich and J.N. Fiessinger; R. Beauchant Hospital, Poitiers: J. Allal; Clinique de la Jomayère, Saint-Etienne: J.M. Gallot-Lavallée; Avicenne Hospital, Bobigny: L. Guillevin; Pellegrin Hospital, Bordeaux: G. Sassous; Intercommunal Hospital, Fréjus: R. Mossaz; Emile Roux Hospital, Le Puy: J.P. Saboye and M. Viallet; Croix Rousse Hospital, Lyons: J.C. Guerin; Salvator Hospital, Marseilles: J.M. Sainty; La Beauchée Hospital, St. Brieuc: F. Zimbacca; General Hospital, St. Chamond: J.H. Payre; Purpan Hospital, Toulouse: A. Barret; Steering Committee: H. Decousus, Y. Page, X. Barral, L. Barritault, H. Boccalon, J.P. Boissel, P. Carpentier, B. Charbonnier, J.N. Fiessinger, Y. Huet, A. Leizorovicz, J. Marzelle, G. Meyer, E. Neuhart, H. Rousseau, and G. Simonneau; Adjudication Committee: P. Girard, M. Defour-Decousus, P. Hervé, and C. Lamer; Independent Supervision Committee: M.M. Samama, C. Caulin, and C. Chastang; Permanent Guest: A. Leizorovicz; Coordinating Center: Clinical Pharmacology Unit, Bellevue Hospital, Saint-Etienne: H. Decousus, A. Buchmuller, A. Devillard, D. Ollagnon, and B. Chastel; Central Data Management Offices: Clinical Pharmacology Unit, Bellevue Hospital, Saint-Etienne: S. Laporte and E. Venet; Clinical Pharmacology Unit, Cardiological Hospital, Lyons: A. Leizorovicz, S. Delair, and C. Fernandez; Sponsor: Bellon Rhône–Poulenc Rorer Laboratories, Montrouge: Y. Huet, E. Neuhart, P. Ill, and J.Y. Darmon; Cosponsors: Ministère Français de la Santé, Caisse Nationale d'Assurance Maladie, Structure Régionale d'Evaluation Interhospitalière Rhône-Alpes, Fondation de l'Avenir, Laboratoire B. Braun France, Laboratoires Diagnostica Stago France.
- References
References
1
Phlegmatia alba dolens. In: Trousseau A. Clinique médicale de l'Hôtel-Dieu de Paris. 3rd ed. Vol. 3. Paris: J.B. Baillière, 1868:652-95.
2
Greenfield LJ ,Michna BA . Twelve-year clinical experience with the Greenfield vena cava filter. Surgery 1988;104:706-712
Web of Science | Medline3
Hyers TM ,Hull RD ,Weg JG . Antithrombotic therapy for venous thromboembolic disease. Chest 1995;108:Suppl:335S-351S
CrossRef | Web of Science | Medline4
Leizorovicz A . Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis: an updated meta-analysis. Drugs 1996;52:Suppl 7:30-37
CrossRef | Web of Science | Medline5
Becker DM ,Philbrick JT ,Selby JB . Inferior vena cava filters: indications, safety, effectiveness. Arch Intern Med 1992;152:1985-1994
CrossRef | Web of Science | Medline6
Hirsh J ,Hoak J . Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals. Circulation 1996;93:2212-2245
Web of Science | Medline7
Page Y ,Decousus H ,Tardy B , et al. Criteria for prophylactic caval interruption in venous thromboembolism: a survey. Am Rev Respir Dis 1993;147:Suppl:A1001-A1001 abstract.
Web of Science8
Walsh DB ,Birkmeyer JD ,Barrett JA ,Kniffin WB ,Cronenwett JL ,Baron JA . Use of inferior vena cava filters in the Medicare population. Ann Vasc Surg 1995;9:483-487
CrossRef | Web of Science | Medline9
Greenfield LJ ,Proctor MC . Current indications for caval interruption: should they be liberalized in view of improving technology? Semin Vasc Surg 1996;9:50-58
Medline10
Magnant JG ,Walsh DB ,Juravsky LI ,Cronenwett JL . Current use of inferior vena cava filters. J Vasc Surg 1992;16:701-706
CrossRef | Web of Science | Medline11
Alexander JJ ,Gewertz BL ,Lu C-T ,Zarins CK . New criteria for placement of a prophylactic vena cava filter. Surg Gynecol Obstet 1986;163:405-409
Web of Science | Medline12
Kinasewitz GT . Thrombophlebitis and pulmonary embolism in the elderly patient. Clin Chest Med 1993;14:523-536
Web of Science | Medline13
Pomper SR ,Lutchman G . The role of intracaval filters in patients with COPD and DVT. Angiology 1991;42:85-89
CrossRef | Web of Science | Medline14
Fink JA ,Jones BT . The Greenfield filter as the primary means of therapy in venous thromboembolic disease. Surg Gynecol Obstet 1991;172:253-256
Web of Science | Medline15
Cohen JR ,Tenenbaum N ,Citron M . Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery 1991;109:12-15
Web of Science | Medline16
Golueke PJ ,Garrett WV ,Thompson JE ,Smith BL ,Talkington CM . Interruption of the vena cava by means of the Greenfield filter: expanding the indications. Surgery 1988;103:111-117
Web of Science | Medline17
Berry RE ,George JE ,Shaver WA . Free-floating deep venous thrombosis: a retrospective analysis. Ann Surg 1990;211:719-723
CrossRef | Web of Science | Medline18
Dorfman GS . Evaluating the roles and function of vena caval filters: will data be available before or after these devices are removed from the market? Radiology 1992;185:15-17
Web of Science | Medline19
Goldhaber SZ . A free-floating approach to filters. Arch Intern Med 1997;157:264-265
CrossRef | Web of Science | Medline20
The PIOPED Investigators
CrossRef | Web of Science21
Moser KM ,Longo AM ,Ashburn WL ,Guisan M . Spurious scintiphotographic recurrence of pulmonary emboli. Am J Med 1973;55:434-443
CrossRef | Web of Science | Medline22
Girard P ,Mathieu M ,Simonneau G , et al. Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study. Thorax 1987;42:481-486
CrossRef | Web of Science | Medline23
Brandjes DPM ,Heijboer H ,Buller HR ,de Rijk M ,Jagt H ,ten Cate JW . Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327:1485-1489
Full Text | Web of Science | Medline24
Prandoni P ,Cogo A ,Bernardi E , et al. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation 1993;88:1730-1735
Web of Science | Medline25
Hull RD ,Raskob GE ,Hirsh J , et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-1114
Full Text | Web of Science | Medline26
Hull RD ,Raskob GE ,Rosenbloom D , et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260-1264
Full Text | Web of Science | Medline27
Byar DP ,Piantadosi S . Factorial designs for randomized clinical trials. Cancer Treat Rep 1985;69:1055-1063
Medline28
Tardy B ,Mismetti P ,Page Y , et al. Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases. Eur Respir J 1996;9:2012-2016
CrossRef | Web of Science | Medline29
The Columbus Investigators
Full Text | Web of Science | Medline30
Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972;287:324-7.
- Citing Articles (419)
Citing Articles
1
Jeffrey B Geske, Sean B Smith, Timothy I Morgenthaler, Sunil V Mankad. (2012) Care of patients with acute pulmonary emboli: a clinical review with cardiovascular focus. Expert Review of Cardiovascular Therapy 10:2, 235-250
CrossRef2
Paul D. Stein, Fadi Matta, Daniel C. Keyes, Gary L. Willyerd. (2012) Impact of Vena Cava Filters on In-Hospital Case Fatality Rate from Pulmonary Embolism. The American Journal of Medicine
CrossRef3
Frederick A. Spencer, Aimee Kroll, Darleen Lessard, Cathy Emery, Alla V. Glushchenko, Luigi Pacifico, George Reed, Joel M. Gore, Robert J. Goldberg. (2012) Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study. Journal of Thrombosis and Thrombolysis
CrossRef4
Mohsen Sharifi, Curt Bay, Laura Skrocki, David Lawson, Shahnaz Mazdeh. (2012) Role of IVC Filters in Endovenous Therapy for Deep Venous Thrombosis: The FILTER-PEVI (Filter Implantation to Lower Thromboembolic Risk in Percutaneous Endovenous Intervention) Trial. CardioVascular and Interventional Radiology
CrossRef5
Davide Imberti, Walter Ageno, Francesco Dentali, Marco Donadini, Roberto Manfredini, Massimo Gallerani. (2012) Retrievable vena cava filters: a clinical review. Journal of Thrombosis and Thrombolysis
CrossRef6
Joyce S Balami, Alastair M Buchan. (2012) Complications of intracerebral haemorrhage. The Lancet Neurology 11:1, 101-118
CrossRef7
Ernest Kwek, Richard E. Buckley. 2011. Thromboprophylaxis in Orthopedic Practice. , 56-71.
CrossRef8
Luis F. Angel, Victor Tapson, Richard E. Galgon, Marcos I. Restrepo, John Kaufman. (2011) Systematic Review of the Use of Retrievable Inferior Vena Cava Filters. Journal of Vascular and Interventional Radiology 22:11, 1522-1530.e3
CrossRef9
James M. Hunt, Todd M. Bull. (2011) Clinical Review of Pulmonary Embolism: Diagnosis, Prognosis, and Treatment. Medical Clinics of North America 95:6, 1203-1222
CrossRef10
Murat Turfan, Mehmet Akif Vatankulu, Sani Namik Murat, Fatih Oksuz, Mustafa Duran, Ender Ornek. (2011) Thrombolytic Treatment of Simultaneous Pulmonary Embolism and Impending Paradoxical Embolism Through a Patent Foramen Ovale: A Different Thrombolytic Regimen. Heart, Lung and Circulation
CrossRef11
Terence K.B. Teo, John F. Angle, John I. Shipp, Michael K. Bluett, Charles A. Gilliland, Ulku C. Turba, Alan H. Matsumoto. (2011) Incidence and Management of Inferior Vena Cava Filter Thrombus Detected at Time of Filter Retrieval. Journal of Vascular and Interventional Radiology 22:11, 1514-1520
CrossRef12
Jonathan Sebunya, Dominik Baschera, Patrick Isenegger, Rene Zellweger. (2011) Optional inferior vena cava filter use in surgical patients: a Western Australian experience. ANZ Journal of Surgery 81:11, 804-809
CrossRef13
Davide Imberti, Walter Ageno, Roberto Manfredini, Fabio Fabbian, Raffaella Salmi, Rita Duce, Massimo Gallerani. (2011) Interventional treatment of venous thromboembolism: A review. Thrombosis Research
CrossRef14
F. Couturaud. (2011) Durée optimale du traitement anticoagulant au décours d’une embolie pulmonaire. Revue des Maladies Respiratoires
CrossRef15
Lindsay M. Fairfax, Ronald F. Sing. (2011) Vena Cava Interruption. Critical Care Clinics 27:4, 781-804
CrossRef16
Anne G. McLeod, William Geerts. (2011) Venous Thromboembolism Prophylaxis in Critically Ill Patients. Critical Care Clinics 27:4, 765-780
CrossRef17
Khashayar Vaziri, J. Devin Watson, Amy P. Harper, Juliet Lee, Fredrick J. Brody, Shawn Sarin, Elizabeth A. Ignacio, Albert Chun, Anthony C. Venbrux, Paul P. Lin. (2011) Prophylactic Inferior Vena Cava Filters in High-Risk Bariatric Surgery. Obesity Surgery 21:10, 1580-1584
CrossRef18
Bruno Damascelli, Vladimira Ticha, Gianluigi Patelli, Rodolfo Lanocita, Carlo Morosi, Enrico Civelli, Giuseppe Di Tolla, Laura Francesca Frigerio, Elisa Ciceri, Francesco Garbagnati, Carlo Spreafico, Paola Amadeo, Alfonso Marchianò. (2011) Use of a Retrievable Vena Cava Filter with Low-intensity Anticoagulation for Prevention of Pulmonary Embolism in Patients with Cancer: An Observational Study in 106 Cases. Journal of Vascular and Interventional Radiology 22:9, 1312-1319
CrossRef19
Frank C. Lynch. (2011) A Method for Following Patients with Retrievable Inferior Vena Cava Filters: Results and Lessons Learned from the First 1,100 Patients. Journal of Vascular and Interventional Radiology
CrossRef20
Suzanne M. Gillern, Forest R. Sheppard, Korboi N. Evans, J. Christopher Graybill, Frederick A. Gage, Jonathan A. Forsberg, James R. Dunne, Douglas K. Tadaki, Eric A. Elster. (2011) Incidence of Pulmonary Embolus in Combat Casualties With Extremity Amputations and Fractures. The Journal of Trauma: Injury, Infection, and Critical Care 71:3, 607-613
CrossRef21
M. Mandala, A. Falanga, F. Roila, . (2011) Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology 22:Supplement 6, vi85-vi92
CrossRef22
Nancy Torres Finnerty, Franklin Michota. 2011. Prevention of Venous Thromboembolism in Surgical Patients. , 107-136.
CrossRef23
Tracy Minichiello, Lauren Doctoroff, Elizabeth A. Farrell. 2011. Treatment of Acute Venous Thromboembolism in Hospitalized Patients. , 137-160.
CrossRef24
Guo Ya-Juan, Feng Jun, Qu Tian-Rong, Qu Yan, Liu Ya-Min, Zhang Yu-Shun, Tian Hong-Yan, Ma Ai-Qun. (2011) Vena cava thrombosis after vena cava filter placement: Incidence and risk factors. Journal of Geriatric Cardiology 8:2, 99-103
CrossRef25
Antonios P. Gasparis, Georgios Spentzouris, Robert J. Meisner, Doreen Elitharp, Nicos Labropoulos, Apostolos Tassiopoulos. (2011) Improving retrieval rates of temporary inferior vena cava filters. Journal of Vascular Surgery
CrossRef26
Colette M. Shaw, Leslie B. Scorza, Peter N. Waybill, Harjit Singh, Frank C. Lynch. (2011) Optional Vena Cava Filter Use in the Elderly Population. Journal of Vascular and Interventional Radiology 22:6, 824-828
CrossRef27
XiXiang Gao, Jian Zhang, Bing Chen, HengXi Yu, JianXin Li, ShuWen Zhang, ZengGuo Feng, Lin Ye, Jian Han. (2011) A New Self-Convertible Inferior Vena Cava Filter: Experimental In-vitro and In-vivo Evaluation. Journal of Vascular and Interventional Radiology 22:6, 829-834
CrossRef28
Zafar Iqbal, Marc Cohen. (2011) Enoxaparin: a pharmacologic and clinical review. Expert Opinion on Pharmacotherapy 12:7, 1157-1170
CrossRef29
Summer B. Dewdney, Teri Benn, B.J. Rimel, Feng Gao, Nael Saad, Suresh Vedantham, David G. Mutch, Israel Zighelboim. (2011) Inferior vena cava filter placement in the gynecologic oncology patient: A 15-year institutional experience. Gynecologic Oncology 121:2, 344-346
CrossRef30
2011. References. , 193-223.
CrossRef31
Jeong Kye Hwang, Ji Il Kim, Sang Dong Kim, Kyung J. Cho, In Sung Moon. (2011) Surgical Removal of a Günther Tulip Filter With Symptomatic Caval Penetration After Unsuccessful Percutaneous Retrieval. Annals of Vascular Surgery
CrossRef32
Frank C. Lynch. (2011) Removal of a Günther Tulip Filter after 3,006 Days. Journal of Vascular and Interventional Radiology 22:3, 337-340
CrossRef33
Thuong G. Van Ha, Patrick Dillon, Brian Funaki, Steve Zangan, Jonathan Lorenz, Giancarlo Piano, Sidney Regalado. (2011) Use of Retrievable Filters in Alternative Common Iliac Vein Location in High-risk Surgical Patients. Journal of Vascular and Interventional Radiology 22:3, 325-329
CrossRef34
Marcus J. Pianta, Kenneth R. Thomson. (2011) Catheter-Directed Thrombolysis of Lower Limb Thrombosis. CardioVascular and Interventional Radiology 34:1, 25-36
CrossRef35
Ramadass Satya, Arya Bagherpour, Melanie Christofferson, Radhika J. Satya. (2011) Large saddle pulmonary embolism in patient with previously placed IVC filter: A case report of successful Angiojet thrombectomy. Respiratory Medicine CME 4:3, 133-135
CrossRef36
J.-B. Ricco. (2011) Interruzione della vena cava inferiore. EMC - Tecniche Chirurgiche Vascolare 16:3, 1-20
CrossRef37
John C. Oh, Scott O. Trerotola, Mandeep Dagli, Richard D. Shlansky-Goldberg, Michael C. Soulen, Maxim Itkin, Jeffrey Mondschein, Jeffrey Solomon, S. William Stavropoulos. (2011) Removal of Retrievable Inferior Vena Cava Filters with Computed Tomography Findings Indicating Tenting or Penetration of the Inferior Vena Cava Wall. Journal of Vascular and Interventional Radiology 22:1, 70-74
CrossRef38
J.-B. Ricco. (2011) Interrupción de la vena cava inferior. EMC - Cirugía General 11:1, 1-20
CrossRef39
Emily L. Spangler, Ellen D. Dillavou, Kenneth J. Smith. (2010) Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients. Journal of Vascular Surgery 52:6, 1537-1545.e2
CrossRef40
Wee Shian Chan. (2010) Venous thromboembolism in pregnancy. Expert Review of Cardiovascular Therapy 8:12, 1731-1740
CrossRef41
Victor F. Tapson. (2010) Interventional Therapies for Venous Thromboembolism: Vena Caval Interruption, Surgical Embolectomy, and Catheter-Directed Interventions. Clinics in Chest Medicine 31:4, 771-781
CrossRef42
K. A. Bauer. (2010) Duration of Anticoagulation: Applying the Guidelines and Beyond. Hematology 2010:1, 210-215
CrossRef43
Yen-Ting Lin, I-Chen Tsai, Wei-Lin Tsai, Min-Chi Chen, Pao-Chun Lin, Si-Wa Chan, Clayton Chi-Chang Chen. (2010) Comprehensive evaluation of patients suspected with deep vein thrombosis using indirect CT venography with multi-detector row technology: from protocol to interpretation. The International Journal of Cardiovascular Imaging 26:S2, 311-322
CrossRef44
Clive Kearon. (2010) Long-term Anticoagulation for Venous Thromboembolism: Duration of Treatment and Management of Warfarin Therapy. Clinics in Chest Medicine 31:4, 719-730
CrossRef45
Jeet Minocha, Ibrahim Idakoji, Ahsun Riaz, Jennifer Karp, Ramona Gupta, Howard B. Chrisman, Riad Salem, Robert K. Ryu, Robert J. Lewandowski. (2010) Improving Inferior Vena Cava Filter Retrieval Rates: Impact of a Dedicated Inferior Vena Cava Filter Clinic. Journal of Vascular and Interventional Radiology 21:12, 1847-1851
CrossRef46
Peter H. Gorman. (2010) Reply to the Letter to the Editor: The Need for a Prospective Trial of Inferior Vena Cava Filter Placement After Acute Spinal Cord Injury. The Journal of Trauma: Injury, Infection, and Critical Care 69:4, 1003-1004
CrossRef47
Petra MG Erkens, Martin H Prins, Martin H Prins. 2010. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. .
CrossRef48
Rachna Raman, Philip D. Leming, Manish Bhandari, Daniel Long, Michael B. Streiff. (2010) Inferior vena cava filters in the management of cancer-associated venous thromboembolism: a systematic review. Oncology Reviews 4:3, 147-157
CrossRef49
David R. King, George C. Velmahos. (2010) Difficulties in managing the surgical patient who is morbidly obese. Critical Care Medicine 38, S478-S482
CrossRef50
D. Baschera, J. Sebunya, C. Walter, R. Zellweger. (2010) Vena-cava-Filter bei unfallchirurgischen Patienten. Der Unfallchirurg 113:9, 764-769
CrossRef51
Fred Usoh, Anil Hingorani, Enrico Ascher, Alexander Shiferson, Nirav Patel, Kapil Gopal, Natalia Marks, Theresa Jacob. (2010) Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters. Journal of Vascular Surgery 52:2, 394-399
CrossRef52
Matthew S. Johnson, Albert A. Nemcek, James F. Benenati, Dirk S. Baumann, Bart L. Dolmatch, John A. Kaufman, Mark J. Garcia, Michael S. Stecker, Anthony C. Venbrux, Ziv J. Haskal, Rui L. Avelar. (2010) The Safety and Effectiveness of the Retrievable Option Inferior Vena Cava Filter: A United States Prospective Multicenter Clinical Study. Journal of Vascular and Interventional Radiology 21:8, 1173-1184
CrossRef53
Brian M. Kelly, Brian M. Yoder, Chi-Tsai Tang, Thomas W. Wakefield. (2010) Venous Thromboembolic Events in the Rehabilitation Setting. PM&R 2:7, 647-663
CrossRef54
Celso Arrais Rodrigues, Renata Ferrarotto, Roberto Kalil Filho, Yana A. S. Novis, Paulo M. G. Hoff. (2010) Venous thromboembolism and cancer: a systematic review. Journal of Thrombosis and Thrombolysis 30:1, 67-78
CrossRef55
Matthew J. Martin, Kelly S. Blair, Thomas K. Curry, Niten Singh. (2010) Vena Cava Filters: Current Concepts and Controversies for the Surgeon. Current Problems in Surgery 47:7, 524-618
CrossRef56
S. Leong, F. Oisin, J. E. Barry, M. M. Maher, C. O. Bogue. (2010) Bilateral inferior vena cava filter insertion in a patient with duplication of the infrarenal vena cava. Irish Journal of Medical Science
CrossRef57
Catherine Nelson-Piercy, Ian Greer. 2010. Thromboembolic Disease in Pregnancy. , 82-100.
CrossRef58
Sergio Savastano, Beghetto Mario, Jacopo Dall’Acqua, Giuseppe Mansi. (2010) A Right Common Iliac Artery Pseudoaneurysm with an Iliac-Caval Arteriovenous Fistula: A Rare Complication of the Recovery Vena Cava Filter. CardioVascular and Interventional Radiology 33:3, 667-669
CrossRef59
Mohammad Arabi, Jonathan M. Willatt, James J. Shields, Kyung J. Cho, Wojciech B. Cwikiel. (2010) Retrievability of Optional Inferior Vena Cava Filters with Caudal Migration and Caval Penetration: Report of Three Cases. Journal of Vascular and Interventional Radiology 21:6, 923-926
CrossRef60
Juno Deguchi, Mikiko Nagayoshi, Takuya Miyahara, Seiji Nishikage, Hideo Kimura, Kunihiro Shigematsu, Tetsuro Miyata. (2010) Do inferior vena cava filters reduce the risk of acute pulmonary embolism in preoperative patients with venous thromboembolism?. Surgery Today 40:6, 533-537
CrossRef61
Nsikak J. Umoh, Christopher M. Alessi, David P. Franklin, Anthony O. Udekwu. (2010) Small Bowel Volvulus in a Quadriplegic: A Rare Complication of the Simon Nitinol Inferior Vena Cava Filter. European Journal of Trauma and Emergency Surgery 36:3, 250-253
CrossRef62
A. RAJASEKHAR, M. CROWTHER. (2010) Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature. Journal of Thrombosis and Haemostasis 8:6, 1266-1270
CrossRef63
Lori-Ann Linkins, Clive Kearon. 2010. Venous Thromboembolism. , 135-146.
CrossRef64
Christopher D. Killingsworth, Steven M. Taylor, Mark A. Patterson, Jordan A. Weinberg, Gerald McGwin, Sherry M. Melton, Donald A. Reiff, Jeffrey D. Kerby, Loring W. Rue, William D. Jordan, Marc A. Passman. (2010) Prospective implementation of an algorithm for bedside intravascular ultrasound-guided filter placement in critically ill patients. Journal of Vascular Surgery 51:5, 1215-1221
CrossRef65
Naritatsu Saito, Takeshi Shimamoto, Takahide Takeda, Akira Marui, Takeshi Kimura, Tadashi Ikeda, Ryuzo Sakata. (2010) Excimer Laser–assisted Retrieval of Günther Tulip Vena Cava Filters: A Pilot Study in a Canine Model. Journal of Vascular and Interventional Radiology 21:5, 719-724
CrossRef66
Paul D. Stein, Fadi Matta, Muzammil H. Musani, Benjamin Diaczok. (2010) Silent Pulmonary Embolism in Patients with Deep Venous Thrombosis: A Systematic Review. The American Journal of Medicine 123:5, 426-431
CrossRef67
John F. Mission, Robert K. Kerlan, Justin H. Tan, Margaret C. Fang. (2010) Rates and Predictors of Plans for Inferior Vena Cava Filter Retrieval in Hospitalized Patients. Journal of General Internal Medicine 25:4, 321-325
CrossRef68
Aslihan Semiz-Oysu, Kyung J. Cho. (2010) The Günther-Tulip Retrievable Filter: A Method for Assessing Tilting of the Filter. Heart, Lung and Circulation 19:4, 228-233
CrossRef69
Iftikhar Ahmad, Kalpana Yeddula, Stephan Wicky, Sanjeeva P. Kalva. (2010) Clinical Sequelae of Thrombus in an Inferior Vena Cava Filter. CardioVascular and Interventional Radiology 33:2, 285-289
CrossRef70
M. Aleksic, K. Balzer, K. Kröger, S. Pourhassan. (2010) Vena-cava-Filter. Gefässchirurgie 15:2, 120-124
CrossRef71
A. Willeke, E. Lindhoff-Last. (2010) Therapie der venösen Thromboembolie. Der Internist 51:3, 335-343
CrossRef72
Tim Young, Hangwi Tang, Rodney Hughes, Tim Young. 2010. Vena caval filters for the prevention of pulmonary embolism. .
CrossRef73
Takuji Yamagami, Osamu Tanaka, Rika Yoshimatsu, Hiroshi Miura, Tsunehiko Nishimura. (2010) Venous Thromboembolism After Removal of Retrievable Inferior Vena Cava Filters. CardioVascular and Interventional Radiology 33:1, 74-79
CrossRef74
Deborah J. Cook, Mark A. Crowther. (2010) Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients. Critical Care Medicine 38, S76-S82
CrossRef75
Cynthia Wu, Agnes Y. Lee. (2010) Malignancy and venous thrombosis in the critical care patient. Critical Care Medicine 38, S64-S70
CrossRef76
Andrew S. Neviaser, Charles Chang, Stephen Lyman, Alejandro Gonzales Della Valle, Steven B. Haas. (2010) High Incidence of Complications From Enoxaparin Treatment After Arthroplasty. Clinical Orthopaedics and Related Research® 468:1, 115-119
CrossRef77
Stephen M. Pastores, Louis P. Voigt. (2010) Acute Respiratory Failure in the Patient with Cancer: Diagnostic and Management Strategies. Critical Care Clinics 26:1, 21-40
CrossRef78
A. Le Guyader, M. Laskar. (2010) Trattamento chirurgico dell’embolia polmonare acuta. EMC - Tecniche Chirurgiche Torace 14:1, 1-7
CrossRef79
John H Rundback, Adam Zybulewski, Joseph Manno. (2010) Permanent or temporary IVC filtration with a novel double-ring anchoring technology optional nitinol filter. Expert Review of Medical Devices 7:1, 11-19
CrossRef80
Dominique Farge, Lise Bosquet, Diana Kassab-Chahmi, Patrick Mismetti, Ismail Elalamy, Guy Meyer, Francis Cajfinger, Hélène Desmurs-Clavel, Antoine Elias, Claire Grange, Hamid Hocini, Grégoire Legal, Isabelle Mahe, Isabelle Quéré, Hervé Levesque, Philippe Debourdeau. (2010) 2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group. Critical Reviews in Oncology/Hematology 73:1, 31-46
CrossRef81
Joseph J. McBride, Audra A. Duncan, Raymond Shields, Barbara Gfeller, Anthony W. Stanson. (2010) Percutaneous Blunt Dissection Technique for Retrieval of Over-the-wire Greenfield Filters. Journal of Vascular and Interventional Radiology 21:1, 144-147
CrossRef82
Filip Banovac, Donna C. Buckley, William T. Kuo, Denver Matthew Lough, Louis G. Martin, Steven F. Millward, Timothy W.I. Clark, Sanjoy Kundu, Dheeraj K. Rajan, David Sacks, John F. Cardella. (2010) Reporting Standards for Endovascular Treatment of Pulmonary Embolism. Journal of Vascular and Interventional Radiology 21:1, 44-53
CrossRef83
Joshua Broder. 2010. “Therapeutic Imaging”: Image-Guided Therapies in Emergency Medicine. , e1-e35.
CrossRef84
Thomas S. Helling, Sumesh Kaswan, S Lee Miller, James F. Tretter. (2009) Practice Patterns in the Use of Retrievable Inferior Vena Cava Filters in a Trauma Population: A Single-Center Experience. The Journal of Trauma: Injury, Infection, and Critical Care 67:6, 1293-1296
CrossRef85
Peter Schratzberger. (2009) Akute Pulmonalembolie. Wiener klinische Wochenschrift Education 4:3-4, 141-152
CrossRef86
Davide Imberti, Marcello Di Nisio, Maria Benedetta Donati, Anna Falanga, Angelo Ghirarduzzi, Daniele Guarneri, Franco Piovella, Rita Carlotta Santoro, Edoardo Baldini, Stefania Zampogna. (2009) Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thrombosis Research 124:5, e32-e40
CrossRef87
Farouk Mookadam, Martina Mookadam, Panupong Jiamsripong, Ramil Goel. (2009) Pulmonary thromboembolic disease spectrum: diagnostic and therapeutic strategies. Expert Review of Cardiovascular Therapy 7:11, 1421-1428
CrossRef88
H. Worth. (2009) Aktuelles Management der akuten Lungenembolie. Der Pneumologe 6:6, 378-389
CrossRef89
Christoph A. Binkert, Alain T. Drooz, James G. Caridi, Mark J. Sands, Haraldur Bjarnason, Frank C. Lynch, William S. Rilling, Domenic A. Zambuto, S. William Stavropoulos, Anthony C. Venbrux, John A. Kaufman. (2009) Technical Success and Safety of Retrieval of the G2 Filter in a Prospective, Multicenter Study. Journal of Vascular and Interventional Radiology 20:11, 1449-1453
CrossRef90
Guido Finazzi, Giulio Mingardi. (2009) Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?. Internal and Emergency Medicine 4:5, 375-380
CrossRef91
Conor O. Bogue, Philip R. John, Bairbre L. Connolly, David J. Rea, Joao G. Amaral. (2009) Symptomatic caval penetration by a Celect inferior vena cava filter. Pediatric Radiology 39:10, 1110-1113
CrossRef92
Sarah Ingber, William H Geerts. (2009) Vena caval filters: current knowledge, uncertainties and practical approaches. Current Opinion in Hematology 16:5, 402-406
CrossRef93
Herb A. Phelan, Richard P. Gonzalez, William C. Scott, Cassandra Q. White, Michael McClure, Joseph P. Minei. (2009) Long-term Follow-up of Trauma Patients With Permanent Prophylactic Vena Cava Filters. The Journal of Trauma: Injury, Infection, and Critical Care 67:3, 485-489
CrossRef94
L.-C. Linke. (2009) Therapie der postoperativen Thrombose. Der Orthopäde 38:9, 812-817
CrossRef95
Marianne Tschoe, Hyun S. Kim, Daniel J. Brotman, Michael B. Streiff. (2009) Retrievable vena cava filters: A clinical review. Journal of Hospital Medicine 4:7, 441-448
CrossRef96
Erin H Murphy, Eric D Johnson, George E Kopchok, Thomas J Fogarty, Frank R Arko. (2009) Crux ® vena cava filter. Expert Review of Medical Devices 6:5, 477-485
CrossRef97
Rachel M. Holden, Catherine M. Clase. (2009) Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis. Seminars in Dialysis 22:5, 503-511
CrossRef98
Sarfraz Ahmed Nazir, Arul Ganeshan, Sheraz Nazir, Raman Uberoi. (2009) Endovascular Treatment Options in the Management of Lower Limb Deep Venous Thrombosis. CardioVascular and Interventional Radiology 32:5, 861-876
CrossRef99
Kenji Ishihara, Shinichi Hiromatsu, Yusuke Shintani, Kurando Kanaya, Keita Mikasa, Shigeaki Aoyagi. (2009) Clinical outcome of perioperative nonpermanent vena cava filter placement in patients with deep venous thrombosis or blood stasis of the vein. Surgery Today 39:9, 764-769
CrossRef100
Suhail Allaqaband, Romas Kirvaitis, Fuad Jan, Tanvir Bajwa. (2009) Endovascular Treatment of Peripheral Vascular Disease. Current Problems in Cardiology 34:9, 359-476
CrossRef101
Frank C. Lynch, Stephanie Kekulawela. (2009) Removal of the G2 Filter: Differences between Implantation Times Greater and Less than 180 Days. Journal of Vascular and Interventional Radiology 20:9, 1200-1209
CrossRef102
Ed Parkin, Ferdinand Serracino-Inglott, Nick Chalmers, Vince Smyth. (2009) Symptomatic perforation of a retrievable inferior vena cava filter after a dwell time of 5 years. Journal of Vascular Surgery 50:2, 417-419
CrossRef103
P. Gogalniceanu, C.J.C. Johnston, U. Khalid, P.J.E. Holt, R. Hincliffe, I.M. Loftus, M.M. Thompson. (2009) Indications for Thrombolysis in Deep Venous Thrombosis. European Journal of Vascular and Endovascular Surgery 38:2, 192-198
CrossRef104
Hearns W. Charles, Michelle Black, Sandor Kovacs, Arash Gohari, Joseph Arampulikan, Jeffrey W. McCann, Timothy W.I. Clark, Mona Bashar, David Steiger. (2009) G2 Inferior Vena Cava Filter: Retrievability and Safety. Journal of Vascular and Interventional Radiology 20:8, 1046-1051
CrossRef105
Suresh Vedantham, Clement J. Grassi, Hector Ferral, Nilesh H. Patel, Patricia E. Thorpe, Vittorio P. Antonacci, Bertrand M. Janne d'Othée, Lawrence V. Hofmann, John F. Cardella, Sanjoy Kundu. (2009) Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis. Journal of Vascular and Interventional Radiology 20:7, S391-S408
CrossRef106
Suresh Vedantham, Patricia E. Thorpe, John F. Cardella, Clement J. Grassi, Nilesh H. Patel, Hector Ferral, Lawrence V. Hofmann, Bertrand M. Janne d'Othée, Vittorio P. Antonaci, Elias N. Brountzos. (2009) Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal. Journal of Vascular and Interventional Radiology 20:7, S227-S239
CrossRef107
Steven F. Millward, Clement J. Grassi, Thomas B. Kinney, Sanjoy Kundu, Gary J. Becker, John F. Cardella, Louis G. Martin, James E. Silberzweig, David Sacks. (2009) Reporting Standards for Inferior Vena Caval Filter Placement and Patient Follow-up: Supplement for Temporary and Retrievable/Optional Filters. Journal of Vascular and Interventional Radiology 20:7, S374-S376
CrossRef108
Stephen M. Pastores. (2009) Management of venous thromboembolism in the intensive care unit. Journal of Critical Care 24:2, 185-191
CrossRef109
Gregory Piazza, Samuel Z. Goldhaber. 2009. Thrombolysis for Acute Pulmonary Embolism. , 595-616.
CrossRef110
William MILFORD, Yogesh CHADHA, Karin LUST. (2009) Use of a retrievable inferior vena cava filter in term pregnancy: Case report and review of literature. Australian and New Zealand Journal of Obstetrics and Gynaecology 49:3, 331-333
CrossRef111
John A. Kaufman, John H. Rundback, Stephen T. Kee, William Geerts, David Gillespie, Susan R. Kahn, Clive Kearon, John Rectenwald, Frederick B. Rogers, S. William Stavropoulos. (2009) Development of a Research Agenda for Inferior Vena Cava Filters: Proceedings from a Multidisciplinary Research Consensus Panel. Journal of Vascular and Interventional Radiology 20:6, 697-707
CrossRef112
C.J. Hammond, D.R. Bakshi, R.J. Currie, J.V. Patel, D. Kinsella, R.G. McWilliams, A. Watkinson, A.A. Nicholson. (2009) Audit of the use of IVC filters in the UK: experience from three centres over 12 years. Clinical Radiology 64:5, 502-510
CrossRef113
Martin Köcher, Vera Krcova, Marie Cerna, Martin Prochazka. (2009) Retrievable Günther Tulip Vena Cava Filter in the prevention of pulmonary embolism in patients with acute deep venous thrombosis in perinatal period. European Journal of Radiology 70:1, 165-169
CrossRef114
Agnes Y.Y. Lee. (2009) Treatment of venous thromboembolism in cancer patients. Best Practice & Research Clinical Haematology 22:1, 93-101
CrossRef115
Peter H. Gorman, Syed F. A. Qadri, Anuradha Rao-Patel. (2009) Prophylactic Inferior Vena Cava (IVC) Filter Placement May Increase the Relative Risk of Deep Venous Thrombosis After Acute Spinal Cord Injury. The Journal of Trauma: Injury, Infection, and Critical Care 66:3, 707-712
CrossRef116
Beverley J. Hunt. (2009) The prevention of hospital-acquired venous thromboembolism in the United Kingdom. British Journal of Haematology 144:5, 642-652
CrossRef117
Kasim A. Behranwala, Robin C. N. Williamson. (2009) Cancer-Associated Venous Thrombosis in the Surgical Setting. Annals of Surgery 249:3, 366-375
CrossRef118
O Doody, MF Given, H Kavnoudias, M Street, KR Thomson, SM Lyon. (2009) Initial experience in 115 patients with the retrievable Cook Celect vena cava filter. Journal of Medical Imaging and Radiation Oncology 53:1, 64-68
CrossRef119
Owen N. Johnson, David L. Gillespie, Gilbert Aidinian, Paul W. White, Eric Adams, Charles J. Fox. (2009) The use of retrievable inferior vena cava filters in severely injured military trauma patients. Journal of Vascular Surgery 49:2, 410-416
CrossRef120
R. M. McConville, P. T. Kennedy, A. J. Collins, P. K. Ellis. (2009) Failed Retrieval of an Inferior Vena Cava Filter During Pregnancy Because of Filter Tilt: Report of Two Cases. CardioVascular and Interventional Radiology 32:1, 174-177
CrossRef121
Wen-Sheng Lou, Jian-Ping Gu, Xu He, Liang Chen, Hao-Bo Su, Guo-Ping Chen, Jing-Hua Song, Tao Wang. (2009) Endovascular Treatment for Iliac Vein Compression Syndrome: a Comparison between the Presence and Absence of Secondary Thrombosis. Korean Journal of Radiology 10:2, 135
CrossRef122
P. SINGH, H. M. LAI, R. G. LERNER, T. CHUGH, W. S. ARONOW. (2009) Guidelines and the use of inferior vena cava filters: a review of an institutional experience. Journal of Thrombosis and Haemostasis 7:1, 65-71
CrossRef123
Brian T. Fengler, William J. Brady. (2009) Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm. The American Journal of Emergency Medicine 27:1, 84-95
CrossRef124
J HULL, S ROBERTSON. (2009) Bard Recovery Filter: Evaluation and Management of Vena Cava Limb Perforation, Fracture, and Migration. Journal of Vascular and Interventional Radiology 20:1, 52-60
CrossRef125
T VANHA, O VINOKUR, J LORENZ, S REGALADO, S ZANGAN, G PIANO, B FUNAKI. (2009) Techniques Used for Difficult Retrievals of the Günther Tulip Inferior Vena Cava Filter: Experience in 32 Patients. Journal of Vascular and Interventional Radiology 20:1, 92-99
CrossRef126
Kenneth E. Wood. (2009) A History of Pulmonary Embolism and Deep Venous Thrombosis. Critical Care Clinics 25:1, 115-131
CrossRef127
Konstantinides, Stavros, . (2008) Acute Pulmonary Embolism. New England Journal of Medicine 359:26, 2804-2813
Full Text128
(2008) Guías de práctica clínica sobre diagnóstico y manejo del tromboembolismo pulmonar agudo. Revista Española de Cardiología 61:12, 1330.e1-1330.e52
CrossRef129
Thomas M. Schmelzer, A. Britton Christmas, Dennis A. Taylor, B. Todd Heniford, Ronald F. Sing. (2008) Vena cava filter retrieval in therapeutically anticoagulated patients. The American Journal of Surgery 196:6, 944-947
CrossRef130
Cino Bendinelli, Zsolt Balogh. (2008) Postinjury thromboprophylaxis. Current Opinion in Critical Care 14:6, 673-678
CrossRef131
Thomas W. Wakefield, Joseph Caprini, Anthony J. Comerota. (2008) Thromboembolic Diseases. Current Problems in Surgery 45:12, 844-899
CrossRef132
M. A. Mir. (2008) Superior vena cava filters: hindsight, insight and foresight. Journal of Thrombosis and Thrombolysis 26:3, 257-261
CrossRef133
Miguel Ángel de Gregorio, Alicia Laborda, María Teresa Higuera, Fernando Lostale, Javier Gómez-Arrue, Carolina Serrano, Miguel Ángel Martínez, Américo Viloria. (2008) ¿Cuál es el tiempo límite para retirar un filtro de vena cava? Filtros opcionales de vena cava inferior: recuperación 90 días después de su implantación. Modelo ovino. Archivos de Bronconeumología 44:11, 591-596
CrossRef134
Leslie Raffini, Anne Marie Cahill, Jeffrey Hellinger, Catherine Manno. (2008) A prospective observational study of IVC filters in pediatric patients. Pediatric Blood & Cancer 51:4, 517-520
CrossRef135
MF Given, BC McDonald, P Brookfield, L Niggemeyer, T Kossmann, DK Varma, KR Thomson, SM Lyon. (2008) Retrievable Gunther Tulip inferior vena cava filter: Experience in 317 patients. Journal of Medical Imaging and Radiation Oncology 52:5, 452-457
CrossRef136
Mark A Crowther, Deborah J Cook. (2008) Thromboprophylaxis in medical–surgical critically ill patients. Current Opinion in Critical Care 14:5, 520-523
CrossRef137
D. Ban, S. Yamamoto, H. Kuno, H. Fujimoto, S. Fujita, T. Akasu, Y. Moriya. (2008) A Case of Huge Colon Carcinoma and Right Renal Angiomyolipoma Accompanied by Proximal Deep Venous Thrombosis, Pulmonary Embolism and Tumor Thrombus in the Renal Vein. Japanese Journal of Clinical Oncology 38:10, 710-714
CrossRef138
Emad Monir Zakhary, James R. Elmore, Spencer W. Galt, David P. Franklin. (2008) Optional Filters in Trauma Patients: Can Retrieval Rates Be Improved?. Annals of Vascular Surgery 22:5, 627-634
CrossRef139
Munier Nazzal, Jihad Abbas, Justin Shattu, Mustafa Nazzal. (2008) Complications Secondary to the Bard Retrievable Filter: A Case Report. Annals of Vascular Surgery 22:5, 684-687
CrossRef140
Munier Nazzal, Jihad Abbas, Justin Shattu, Mustafa Nazzal. (2008) Complications du filtre cave amovible Bard. Annales de Chirurgie Vasculaire 22:5, 741-745
CrossRef141
Emad Monir Zakhary, James R. Elmore, Spencer W. Galt, David P. Franklin. (2008) Filtre cave temporaire chez le traumatisé : le taux d'ablation peut-il être amélioré ?. Annales de Chirurgie Vasculaire 22:5, 681-688
CrossRef142
Joel S. Marquess, Charles T. Burke, Ashley H. Beecham, Robert G. Dixon, Joseph M. Stavas, Alan A. Sag, Gary G. Koch, Matthew A. Mauro. (2008) Factors Associated with Failed Retrieval of the Günther Tulip Inferior Vena Cava Filter. Journal of Vascular and Interventional Radiology 19:9, 1321-1327
CrossRef143
Cliff K. Choong, Patrick A. Calvert, Florian Falter, Raj Mathur, Derek Appleton, Francis C. Wells, Peter M. Schofield, Robin Crawford. (2008) Life-threatening impending paradoxical embolus caught “red-handed”: Successful management by multidisciplinary team approach. The Journal of Thoracic and Cardiovascular Surgery 136:2, 527-528.e8
CrossRef144
A. N. Keeling, T. B. Kinney, M. J. Lee. (2008) Optional inferior vena caval filters: where are we now?. European Radiology 18:8, 1556-1568
CrossRef145
Alexander Kadner, Jürg Schmidli, Florian Schönhoff, Eva Krähenbühl, Franz Immer, Thierry Carrel, Friedrich Eckstein. (2008) Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients. The Journal of Thoracic and Cardiovascular Surgery 136:2, 448-451
CrossRef146
Alexander Sauter, Jürgen Triller, Felix Schmidt, Ralph Kickuth. (2008) Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation. CardioVascular and Interventional Radiology 31:S2, 144-148
CrossRef147
Massimiliano Veroux, Tiziano Tallarita, Monica Pennisi, Pierfrancesco Veroux. (2008) Late complication from a retrievable inferior vena cava filter with associated caval, aortic, and duodenal perforation: A case report. Journal of Vascular Surgery 48:1, 223-225
CrossRef148
Jose B. Toro, Michael J. Gardner, Christian Hierholzer, Domenico Sama, Cagri Kosi, William Ertl, David L. Helfet. (2008) Long-Term Consequences of Pelvic Trauma Patients With Thromboembolic Disease Treated With Inferior Vena Caval Filters. The Journal of Trauma: Injury, Infection, and Critical Care 65:1, 25-29
CrossRef149
David B. Marmor, Geno J. Merli, David J. Whellan, Jocelyn Andrel, Tamara Fisicaro, Saum Shamimi-Noori, Suzanne Adams, Alexander Rubin, Arthur M. Feldman. (2008) Relationship of Inferior Vena Cava Filter Usage in Post-Surgical Patients by Various Surgical and Medical Subspecialists. The American Journal of Cardiology 102:2, 226-230
CrossRef150
George C. Velmahos, Hasan B. Alam. (2008) Advances in Surgical Critical Care. Current Problems in Surgery 45:7, 453-516
CrossRef151
M FOX, S KAHN. (2008) Postthrombotic Syndrome in Relation to Vena Cava Filter Placement: A Systematic Review. Journal of Vascular and Interventional Radiology 19:7, 981-985.e3
CrossRef152
Mervyn DI Vergouwen, Yvo BWEM Roos, Pieter W Kamphuisen. (2008) Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury. Current Opinion in Internal Medicine 7:3, 233-239
CrossRef153
Zoya Shmuter, Frede I. Frederic, James R. Gill. (2008) Fatal migration of vena caval filters. Forensic Science, Medicine, and Pathology 4:2, 116-121
CrossRef154
T Adib, A Belli, J McCall, TEJ Ind, JE Bridges, JH Shepherd, DPJ Barton. (2008) The use of inferior vena caval filters prior to major surgery in women with gynaecological cancer. BJOG: An International Journal of Obstetrics & Gynaecology 115:7, 902-907
CrossRef155
Vincent L. Oliva, Pierre Perreault, Marie-France Giroux, Louis Bouchard, Eric Therasse, Gilles Soulez. (2008) Recovery G2 Inferior Vena Cava Filter: Technical Success and Safety of Retrieval. Journal of Vascular and Interventional Radiology 19:6, 884-889
CrossRef156
Peter Spiegler. (2008) RV Enlargement in Pulmonary Embolism. Clinical Pulmonary Medicine 15:3, 182-183
CrossRef157
Kazim Sheikh, Yanming Jiang, Claudia M. Bullock. (2008) Is There a Sex or Race Difference in 30-day Mortality after Interruption of Vena Cava in a Medicare Population?. Journal of Vascular and Interventional Radiology 19:5, 677-682.e1
CrossRef158
Mark Crowther. (2008) The Reply. The American Journal of Medicine 121:4, e7
CrossRef159
Mervyn DI Vergouwen, Yvo BWEM Roos, Pieter W Kamphuisen. (2008) Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury. Current Opinion in Critical Care 14:2, 149-155
CrossRef160
M. Ayaz Mir. (2008) Weighing the Available Evidence: IVC Filters. The American Journal of Medicine 121:4, e5
CrossRef161
L de Villiers, S Mackenzie, H Gibbs, D Leggett, M Neels, J Harper. (2008) Initial Australian experience with the recovery inferior vena cava filter in patients with increased risk of thromboembolic disease. Journal of Medical Imaging and Radiation Oncology 52:2, 124-129
CrossRef162
Teresa L. Carman, Alaa Alahmad. (2008) Update on vena cava filters. Current Treatment Options in Cardiovascular Medicine 10:2, 101-111
CrossRef163
Maithili V Rao, Charles W Francis, Alok A Khorana. 2008. Venous Thromboembolism andAnticoagulation. , 1-29.
CrossRef164
Kivilcim Yavuz, Serdar Geyik, Hanno Hoppe, Kenneth J. Kolbeck, John A. Kaufman. (2008) Venous Thromboembolism after Retrieval of Inferior Vena Cava Filters. Journal of Vascular and Interventional Radiology 19:4, 504-508.e2
CrossRef165
, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, U. Janssens, W. Klepetko, E. Mayer, M. Remy-Jardin, J.-P. Bassand, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , J.-L. Zamorano, F. Andreotti, M. Ascherman, G. Athanassopoulos, J. De Sutter, D. Fitzmaurice, T. Forster, M. Heras, G. Jondeau, K. Kjeldsen, J. Knuuti, I. Lang, M. Lenzen, J. Lopez-Sendon, P. Nihoyannopoulos, L. Perez Isla, U. Schwehr, L. Torraca, J.-L. Vachiery. (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal 29:18, 2276-2315
CrossRef166
Tapson, Victor F., . (2008) Acute Pulmonary Embolism. New England Journal of Medicine 358:10, 1037-1052
Full Text167
Thuong G. Ha, Andy S. Chien, Brian S. Funaki, Jonathan Lorenz, Giancarlo Piano, Maxine Shen, Jeffrey Leef. (2008) Use of Retrievable Compared to Permanent Inferior Vena Cava Filters: A Single-Institution Experience. CardioVascular and Interventional Radiology 31:2, 308-315
CrossRef168
Tracy Minichiello, Patrick F. Fogarty. (2008) Diagnosis and Management of Venous Thromboembolism. Medical Clinics of North America 92:2, 443-465
CrossRef169
Charles E. Ray, Allan Prochazka. (2008) The Need for Anticoagulation Following Inferior Vena Cava Filter Placement: Systematic Review. CardioVascular and Interventional Radiology 31:2, 316-324
CrossRef170
Hyun S. Kim, Mark J. Young, Anand K. Narayan, Kelvin Hong, Robert P. Liddell, Michael B. Streiff. (2008) A Comparison of Clinical Outcomes with Retrievable and Permanent Inferior Vena Cava Filters. Journal of Vascular and Interventional Radiology 19:3, 393-399
CrossRef171
M. K. Urban, K. Jules-Elysee, C. R. MacKenzie. (2008) Pulmonary Embolism after IVC Filter. HSS Journal 4:1, 74-75
CrossRef172
D. Imberti, D. Prisco. (2008) Retrievable vena cava filters: Key considerations. Thrombosis Research 122:4, 442-449
CrossRef173
ARUN SEBASTIAN, DUNCAN F. ETTLES. 2008. Percutaneous vascular intervention in the venous system. , 383-393.
CrossRef174
Tahir E. Yunus, Nabil Tariq, Rose E. Callahan, David J. Niemeyer, O.W. Brown, Gerald B. Zelenock, Charles J. Shanley. (2008) Changes in inferior vena cava filter placement over the past decade at a large community-based academic health center. Journal of Vascular Surgery 47:1, 157-165.e4
CrossRef175
Michael P. Gruber, Todd M. Bull. 2008. Pulmonary Embolism. , 763-781.
CrossRef176
Satoshi Ota, Norikazu Yamada, Akihiro Tsuji, Ken Ishikura, Mashio Nakamura, Naoki Isaka, Masaaki Ito. (2008) The Günther-Tulip Retrievable IVC Filter. Circulation Journal 72:2, 287-292
CrossRef177
Sak Lee, Suk-Won Song, Gijong Yi, Young-Nam Youn, Kyung-Jong Yoo, Byung-Chul Chang. (2008) Open Pulmonary Thromboembolectomy in Patients with Major Pulmonary Thromboembolism. Yonsei Medical Journal 49:6, 973
CrossRef178
Young Sin Cho, Jong Hwa Kim, Ho Sung Lee, Jae Sung Choi, Ju Ock Na, Ki Hyun Seo, Yong Hoon Kim. (2008) A Case of Phlegmasia Cerulea Dolens as a Complication Caused by Placement of Inferior Vena Cava Filter. Tuberculosis and Respiratory Diseases 65:3, 225
CrossRef179
Rob Schuster, Judith C. Hagedorn, Myriam J. Curet, John M. Morton. (2007) Retrievable inferior vena cava filters may be safely applied in gastric bypass surgery. Surgical Endoscopy 21:12, 2277-2279
CrossRef180
Thomas Theologou, Prabhat Tewari, Kate Pointon, Ian M. Mitchell. (2007) Pulmonary Thromboembolism With Floating Thrombus Trapped in Patent Foramen Ovale. The Annals of Thoracic Surgery 84:6, 2104-2106
CrossRef181
Tim Young, Hangwi Tang, John Aukes, Rodney Hughes, Tim Young. 2007. Vena caval filters for the prevention of pulmonary embolism. .
CrossRef182
Amanda J. Ghanim, Constantine Daskalakis, David J. Eschelman, Walter K. Kraft. (2007) A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants. Journal of Thrombosis and Thrombolysis 24:3, 247-254
CrossRef183
T. Seshadri, H. Tran, K. K. Lau, B. Tan, T. E. Gan. (2007) Ins and outs of inferior vena cava filters in patients with venous thromboembolism: the experience at Monash Medical Centre and review of the published reports. Internal Medicine Journal 0:0, 071018054112007-???
CrossRef184
Matthew J. Martin, Ali Salim. (2007) Vena Cava Filters in Surgery and Trauma. Surgical Clinics of North America 87:5, 1229-1252
CrossRef185
Steven R. Shackford, Alan Cook, Frederick B. Rogers, Benjamin Littenberg, Turner Osler. (2007) The Increasing Use of Vena Cava Filters in Adult Trauma Victims: Data From the American College of Surgeons National Trauma Data Bank. The Journal of Trauma: Injury, Infection, and Critical Care 63:4, 764-769
CrossRef186
Arno Buecker, Florian F. Behrendt, Ruth Kn??chel, Sylvia Kinzel, Arne M??lgaard-Nielsen, Joerg Neuerburg, Rolf W. G??nther. (2007) Long-Term Retrieval of Modified G??nther Tulip Vena Cava Filters. Investigative Radiology 42:10, 692-696
CrossRef187
Charles T. Burke, Robert G. Dixon, Joseph M. Stavas. (2007) Use of Rigid Bronchoscopic Forceps in the Difficult Retrieval of the Günther Tulip Inferior Vena Cava Filter. Journal of Vascular and Interventional Radiology 18:10, 1319-1323
CrossRef188
Melvyn Rubenfire, Melike Bayram, Zachary Hector-Word. (2007) Pulmonary Hypertension in the Critical Care Setting: Classification, Pathophysiology, Diagnosis, and Management. Critical Care Clinics 23:4, 801-834
CrossRef189
V. Berczi, J. R. Bottomley, S. M. Thomas, S. Taneja, P. A. Gaines, T. J. Cleveland. (2007) Long-Term Retrievability of IVC Filters: Should We Abandon Permanent Devices?. CardioVascular and Interventional Radiology 30:5, 820-827
CrossRef190
H. H. BILLETT, L. G. JACOBS, E. M. MADSEN, E. R. GIANNATTASIO, S. MAHESH, H. W. COHEN. (2007) Efficacy of inferior vena cava filters in anticoagulated patients. Journal of Thrombosis and Haemostasis 5:9, 1848-1853
CrossRef191
Guillermo Reyes, Akiko Tamura, José L. Guerrero, Luis M. Hernando. (2007) Tratamiento quirúrgico del embolismo pulmonar masivo tras doble parada cardiaca. Revista Española de Cardiología 60:8, 887-889
CrossRef192
Kazunori Inuzuka, Naoki Unno, Naoto Yamamoto, Hiroshi Mitsuoka, Daisuke Sagara, Minoru Suzuki, Motohiro Nishiyama, Hiroyuki Konno. (2007) Hemorrhagic Shock with Delayed Retroperitoneal Hemorrhage After Deployment of an Inferior Vena Cava Filter: Report of a Case. Surgery Today 37:7, 618-621
CrossRef193
I. A. Scott, R. S. Lodge, D. M. Russell. (2007) Evidence-based guide to perioperative medicine. Internal Medicine Journal 37:6, 389-401
CrossRef194
Ma. Jesús Bruscas, José Antonio Nieto, Monserrat Perez-Pinar, Luciano López-Jiménez, Carmen Fernández-Capitán, Francisca López-Chuliá, Ma. Teresa Orue-Lecue, . (2007) Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry. Annals of Hematology 86:7, 519-526
CrossRef195
Takuji Yamagami, Takeharu Kato, Tatsuya Hirota, Rika Yoshimatsu, Tomohiro Matsumoto, Tsunehiko Nishimura. (2007) Evaluation of Retrievability of the Gunther Tulip Vena Cava Filter. CardioVascular and Interventional Radiology 30:2, 226-231
CrossRef196
Michele A. Shermak, David C. Chang, Jennifer Heller. (2007) Factors Impacting Thromboembolism after Bariatric Body Contouring Surgery. Plastic and Reconstructive Surgery 119:5, 1590-1596
CrossRef197
Isabella S. Keller, Christoph Meier, Roger Pfiffner, Emanuela Keller, Thomas Pfammatter. (2007) Clinical Comparison of Two Optional Vena Cava Filters. Journal of Vascular and Interventional Radiology 18:4, 505-511
CrossRef198
Ryan A. Wilcox, Thanila A. Macedo, David E. Midthun. (2007) Nearly 90° from Normal. The American Journal of Medicine 120:2, 148-150
CrossRef199
S. Looby, M.F. Given, T. Geoghegan, A. McErlean, M.J. Lee. (2007) Gunther Tulip Retrievable Inferior Vena Caval Filters: Indications, Efficacy, Retrieval, and Complications. CardioVascular and Interventional Radiology 30:1, 59-65
CrossRef200
John A. Kaufman, Thomas B. Kinney, Michael B. Streiff, Ronald F. Sing, Mary C. Proctor, Daniel Becker, Mark Cipolle, Anthony J. Comerota, Steven F. Millward, Frederick B. Rogers, David Sacks, Anthony C. Venbrux. (2007) Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference. World Journal of Surgery 31:2, 251-264
CrossRef201
David Bergqvist. (2007) Inferior Vena Cava Filters. World Journal of Surgery 31:2, 265-266
CrossRef202
Takahiro Yasui, Nobuhiro Tanabe, Jiro Terada, Noriyuki Yanagawa, Hidefumi Shimizu, Hiroshi Matsubara, Susumu Hoshino, Ayako Fujikawa, Satoko Mizuno, Mari Yatomi, Seiichiro Sakao, Takahiro Uruma, Yasunori Kasahara, Yuichi Takiguchi, Koichiro Tatsumi, Takayuki Kuriyama. (2007) Multidetector-Row Computed Tomography Management of Acute Pulmonary Embolism. Circulation Journal 71:12, 1948-1954
CrossRef203
Matthew T. Rondina, Robert C. Pendleton, Michelle Wheeler, George M. Rodgers. (2007) The treatment of venous thromboembolism in special populations. Thrombosis Research 119:4, 391-402
CrossRef204
H. Worth. (2007) Gerinnungshemmende Therapie der Lungenembolie. Der Pneumologe 4:1, 24-29
CrossRef205
Matthew L. Ortman, Todd E.H. Hecht. 2007. Prevention of Venous Thromboembolism in the Surgical Patient. , 151-222.
CrossRef206
Riyad Karmy-Jones, Gregory J. Jurkovich, George C. Velmahos, Thomas Burdick, Konstantinos Spaniolas, Samuel R. Todd, Michael McNally, Robert C. Jacoby, Daniel Link, Randy J. Janczyk, Felicia A. Ivascu, Michael McCann, Farouck Obeid, William S. Hoff, Nathaniel McQuay, Brandon H. Tieu, Martin A. Schreiber, Ram Nirula, Karen Brasel, Julie A. Dunn, Debbie Gambrell, Roger Huckfeldt, Jayna Harper, Kathryn B. Schaffer, Gail T. Tominaga, Fausto Y. Vinces, David Sperling, David Hoyt, Raul Coimbra, Mathew R. Rosengart, Raquel Forsythe, Clay Cothren, Ernest E. Moore, Elliott R. Haut, Awori J. Hayanga, Linda Hird, Christopher White, Jodi Grossman, Kimberly Nagy, West Livaudais, Rhonda Wood, Imme Zengerink, John B. Kortbeek. (2007) Practice Patterns and Outcomes of Retrievable Vena Cava Filters in Trauma Patients: An AAST Multicenter Study. The Journal of Trauma: Injury, Infection, and Critical Care 62:1, 17-25
CrossRef207
John Evans, Gary Crooks. 2007. Anticoagulation Management in the Surgical Patient. , 223-232.
CrossRef208
Satoshi Morimoto, Takehiko Izumi, Toshiyuki Sakurai, Kimiaki Komukai, Makoto Kawai, Hidenori Yagi, Kenichi Hongo, Takahiro Shibata, Seibu Mochizuki. (2007) Pulmonary Embolism and Deep Vein Thrombosis Complicating Acute Aortic Dissection during Medical Treatment. Internal Medicine 46:8, 477-480
CrossRef209
Giselle G. Hamad, David Bergqvist. (2007) Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surgery for Obesity and Related Diseases 3:1, 97-102
CrossRef210
Samuel Z. Goldhaber. 2007. Deep Vein Thrombosis and Pulmonary Embolism. , 245-256.
CrossRef211
Frederick R. Rickles, Mark Levine. 2007. Thrombosis and Cancer. , 389-403.
CrossRef212
Victor J. Marder. 2007. Thrombolytic Therapy. , 491-501.
CrossRef213
Christine L. Hann, Michael B. Streiff. 2007. Vena Caval Filters. , 531-552.
CrossRef214
R. DuraiRaj, S. Fogarty. (2006) A Penetrating Inferior Vena Caval Filter…. European Journal of Vascular and Endovascular Surgery 32:6, 737-739
CrossRef215
Gregory Piazza, Samuel Z. Goldhaber. (2006) Venous Thromboembolism Guidebook. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:4, 211-227
CrossRef216
B. Lauren Paton, David G. Jacobs, B. Todd Heniford, Kent W. Kercher, Marc Zerey, Ronald F. Sing. (2006) Nine-year experience with insertion of vena cava filters in the intensive care unit. The American Journal of Surgery 192:6, 795-800
CrossRef217
Francesco Dentali, Walter Ageno, Davide Imberti. (2006) Retrievable vena cava filters: clinical experience. Current Opinion in Internal Medicine 5:6, 617-622
CrossRef218
Patrick Y. Wen, David Schiff, Santosh Kesari, Jan Drappatz, Debra C. Gigas, Lisa Doherty. (2006) Medical management of patients with brain tumors. Journal of Neuro-Oncology 80:3, 313-332
CrossRef219
Michael Schweitzer, Kimberley E. Steele, Anne Lidor, Thomas Magnuson. (2006) Acute vena cava thrombosis after placement of retrievable inferior vena cava filter before laparoscopic gastric bypass. Surgery for Obesity and Related Diseases 2:6, 661-663
CrossRef220
Frank Herbstreit, Hilmar K??hl, J??rgen Peters. (2006) A Cemented Caval Vein Filter. Spine 31:24, E917-E919
CrossRef221
Mary C. Carlile, Stuart A. Yablon, W. Jerry Mysiw, Alan B. Frol, David Lo, Ramon Diaz-Arrastia. (2006) Deep Venous Thrombosis Management Following Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 21:6, 483-490
CrossRef222
Rockford C Anderson, Henry I Bussey. (2006) Retrievable and Permanent Inferior Vena Cava Filters: Selected Considerations. Pharmacotherapy 26:11, 1595-1600
CrossRef223
Matthew A Corriere, K Todd Piercy, Matthew S Edwards. (2006) Vena cava filters: an update. Future Cardiology 2:6, 695-707
CrossRef224
Miguel Angel De Gregorio, Pablo Gamboa, Diana L. Bonilla, Maitane Sanchez, Maria T. Higuera, Jokin Medrano, Antonio Mainar, Fernando Lostalé, Alicia Laborda. (2006) Retrieval of Günther Tulip Optional Vena Cava Filters 30 Days after Implantation: A Prospective Clinical Study. Journal of Vascular and Interventional Radiology 17:11, 1781-1789
CrossRef225
2006. Hypertension. .
CrossRef226
Charles E. Ray, Erica Mitchell, Stan Zipser, Edward Y. Kao, Charles F. Brown, Greg L. Moneta. (2006) Outcomes with Retrievable Inferior Vena Cava Filters: A Multicenter Study. Journal of Vascular and Interventional Radiology 17:10, 1595-1604
CrossRef227
Davide Imberti, Walter Ageno, Monica Carpenedo. (2006) Retrievable vena cava filters: a review. Current Opinion in Hematology 13:5, 351-356
CrossRef228
Takuya Miyahara, Tetsuro Miyata, Kunihiro Shigematsu, Juno Deguchi, Hideo Kimura, Shigeyuki Ishii, Hirokazu Nagawa. (2006) Clinical outcome and complications of temporary inferior vena cava filter placement. Journal of Vascular Surgery 44:3, 620-624
CrossRef229
M. Mandalà, A. Falanga, A. Piccioli, P. Prandoni, E.M. Pogliani, R. Labianca, S. Barni. (2006) Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM). Critical Reviews in Oncology/Hematology 59:3, 194-204
CrossRef230
, T. P. Baglin, J. Brush, M. Streiff. (2006) Guidelines on use of vena cava filters. British Journal of Haematology 134:6, 590-595
CrossRef231
Andy C. Chiou. (2006) Intravascular Ultrasound-Guided Bedside Placement of Inferior Vena Cava Filters. Seminars in Vascular Surgery 19:3, 150-154
CrossRef232
Sanjeeva P. Kalva, Christos A. Athanasoulis, Chieh-Min Fan, Marcio Curvelo, Stuart C. Geller, Alan J. Greenfield, Arthur C. Waltman, Stephan Wicky. (2006) “Recovery™” Vena Cava Filter: Experience in 96 Patients. CardioVascular and Interventional Radiology 29:4, 559-564
CrossRef233
Ryuichi Kai, Hiroshi Imamura, Setuo Kumazaki, Yuichi Kamiyoshi, Megumi Koshikawa, Takeshi Hanaoka, Kaoru Kogashi, Jun Koyama, Hiroshi Tsutsui, Yoshikazu Yazaki, Osamu Kinoshita, Uichi Ikeda. (2006) Temporary inferior vena cava filter for deep vein thrombosis and acute pulmonary thromboembolism: effectiveness and indication. Heart and Vessels 21:4, 221-225
CrossRef234
Ramón Lecumberri, Jesús Feliu, Eduardo Rocha. (2006) Tromboembolia venosa en pacientes con cáncer. Medicina Clínica 127:1, 22-32
CrossRef235
Gilles Bovyn, Jean-Baptiste Ricco, Philippe Reynaud, Alain-Ferdinand Le Blanche. (2006) Long-duration temporary vena cava filter: A prospective 104-case multicenter study. Journal of Vascular Surgery 43:6, 1222-1229
CrossRef236
Philippe de Moerloose, Charles Marc Samama, Serge Motte. (2006) Management of venous thromboembolism. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 53:S2, S80-S88
CrossRef237
Rekha N. Mody, LeAnn S. Stokes, Peter R. Bream, Stephanie E. Spottswood. (2006) Removal of a Günther Tulip retrievable inferior vena cava filter after 147 days in a pediatric patient. Pediatric Radiology 36:5, 440-444
CrossRef238
M. Pavic, P. Debourdeau, M. Aletti, D. Farge-Bancel, H. Rousset. (2006) Maladie veineuse thromboembolique et cancer. La Revue de Médecine Interne 27:4, 313-322
CrossRef239
Kenneth J. Kolbeck, Maxim Itkin, Letitia Cheatham, S. William Stavropoulos. (2006) Optional Inferior Vena Cava Filter Retrieval with Retained Thrombus: An in Vitro Model. Journal of Vascular and Interventional Radiology 17:4, 685-691
CrossRef240
M.S. Cunningham, B. White, J. O'Donnell. (2006) Prevention and Management of Venous Thromboembolism in People with Cancer: A Review of the Evidence. Clinical Oncology 18:2, 145-151
CrossRef241
Suresh Vedantham, Clement J. Grassi, Hector Ferral, Nilesh H. Patel, Patricia E. Thorpe, Vittorio P. Antonacci, Bertrand M. Janne d'Othée, Lawrence V. Hofmann, John F. Cardella, Sanjoy Kundu. (2006) Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis. Journal of Vascular and Interventional Radiology 17:3, 417-434
CrossRef242
Suresh Vedantham, Patricia E. Thorpe, John F. Cardella, Clement J. Grassi, Nilesh H. Patel, Hector Ferral, Lawrence V. Hofmann, Bertrand M. Janne d'Othée, Vittorio P. Antonaci, Elias N. Brountzos. (2006) Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal. Journal of Vascular and Interventional Radiology 17:3, 435-448
CrossRef243
John A. Kaufman, Thomas B. Kinney, Michael B. Streiff, Ronald F. Sing, Mary C. Proctor, Daniel Becker, Mark Cipolle, Anthony J. Comerota, Steven F. Millward, Frederick B. Rogers. (2006) Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference. Journal of Vascular and Interventional Radiology 17:3, 449-459
CrossRef244
A.M. Fink, N. Herzog, B. Borst-Krafek, W. Jurecka, A. Steiner. (2006) Long-term Mortality in Patients with Thrombosis of the Inferior Vena Cava, Iliac and Femoral Veins. European Journal of Vascular and Endovascular Surgery 31:2, 200-203
CrossRef245
S. William Stavropoulos, Jeffrey A. Solomon, Scott O. Trerotola. (2006) Wall-embedded Recovery Inferior Vena Cava Filters: Imaging Features and Technique for Removal. Journal of Vascular and Interventional Radiology 17:2, 379-382
CrossRef246
Christoph A. Binkert, Kevin Sasadeusz, S. William Stavropoulos. (2006) Retrievability of the Recovery Vena Cava Filter after Dwell Times Longer than 180 Days. Journal of Vascular and Interventional Radiology 17:2, 299-302
CrossRef247
D ROSENTHAL, E WELLONS, K LAI, A BIKK, V HENDERSON. (2006) Retrievable Inferior Vena Cava Filters: Initial Clinical Results. Annals of Vascular Surgery 20:1, 157-165
CrossRef248
Jared L. Antevil, Michael J. Sise, Daniel I. Sack, Kevin J. Sasadeusz, Sophia M. Swanson, Louis Rivera, Barbara R. Lome, Karl E. Weingarten, Stephen S. Kaminski. (2006) Retrievable Vena Cava Filters for Preventing Pulmonary Embolism in Trauma Patients: A Cautionary Tale. The Journal of Trauma: Injury, Infection, and Critical Care 60:1, 35-40
CrossRef249
T. N. Swaminathan, Howard H. Hu, Aalpen A. Patel. (2006) Numerical Analysis of the Hemodynamics and Embolus Capture of a Greenfield Vena Cava Filter. Journal of Biomechanical Engineering 128:3, 360
CrossRef250
Dorothy S. Lo, Christian G. Rabbat, Catherine M. Clase. (2006) Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical management. Thrombosis Research 118:3, 385-395
CrossRef251
Erhard Hiller. (2006) Cancer and Thrombosis: Managing the Risks and Approaches to Thromboprophylaxis. Onkologie 29:10, 474-478
CrossRef252
Babak Sarani, Albert Chun, Anthony Venbrux. (2005) Role of Optional (Retrievable) IVC Filters in Surgical Patients at Risk for Venous Thromboembolic Disease. Journal of the American College of Surgeons 201:6, 957-964
CrossRef253
N.N. Kirilcuk, E.J. Herget, R.A. Dicker, D.A. Spain, J.C. Hellinger, S.I. Brundage. (2005) Are temporary inferior vena cava filters really temporary?. The American Journal of Surgery 190:6, 864-870
CrossRef254
Marc Meysman, Patrick Haentjens. (2005) Pulmonary embolism: Current treatment options. Current Treatment Options in Cardiovascular Medicine 7:6, 483-490
CrossRef255
David Garcia, Walter Ageno, Edward Libby. (2005) Update on the diagnosis and management of pulmonary embolism. British Journal of Haematology 131:3, 301-312
CrossRef256
Jorge E. Lopera, Junko U. Araki, David Kirsch, Zhong Qian, Augusto Brazzini, Arturo Gonzalez, Wilfrido Castaneda-Zuniga. (2005) A Modified Technique to Minimize Filter Tilting during Deployment of the Günther Tulip Filter: In Vitro Study. Journal of Vascular and Interventional Radiology 16:11, 1539-1544
CrossRef257
Vincent L. Oliva, Ferenc Szatmari, Marie-France Giroux, Bruce K. Flemming, Sidney A. Cohen, Gilles Soulez. (2005) The Jonas Study: Evaluation of the Retrievability of the Cordis OptEase Inferior Vena Cava Filter. Journal of Vascular and Interventional Radiology 16:11, 1439-1445
CrossRef258
Espeel Benoit, Vinciane Crispin, B??n??dicte Fraselle, Brice Payen, Hugues Versailles. (2005) Floating Thrombus Entrapped in a Patent Foramen Ovale Complicating Acute Pulmonary Embolism. Anesthesiology 103:4, 895-897
CrossRef259
Dennis W. Ashley, J William Mix, Benjamin Christie, Charles G. Burton, Frank K. Lochner, George W. McCommon, George C. Matoy, Maurice M. Solis, Robert S. Donner, Martin L. Dalton, Clary S. Tyson, Walter H. Newman. (2005) Removal of the OptEase Retrievable Vena Cava Filter Is Not Feasible after Extended Time Periods Because of Filter Protrusion Through the Vena Cava. The Journal of Trauma: Injury, Infection, and Critical Care 59:4, 847-852
CrossRef260
, , , , , , , , , , , , , , , , . (2005) Interdisziplinäre S2-Leitlinie. Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie. Intensivmedizin und Notfallmedizin 42:7, 552-565
CrossRef261
Robert B. Rutherford. (2005) Prophylactic Indications for Vena Cava Filters: Critical Appraisal. Seminars in Vascular Surgery 18:3, 158-165
CrossRef262
William J. Grande, Scott O. Trerotola, Patrick M. Reilly, Timothy W.I. Clark, Michael C. Soulen, Aalpen Patel, Richard D. Shlansky-Goldberg, Catherine M. Tuite, Jeffrey A. Solomon, Jeffrey I. Mondschein, Mary Kate Fitzpatrick, S. William Stavropoulos. (2005) Experience with the Recovery Filter as a Retrievable Inferior Vena Cava Filter. Journal of Vascular and Interventional Radiology 16:9, 1189-1193
CrossRef263
H. R. BULLER, M. SOHNE, S. MIDDELDORP. (2005) Treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis 3:8, 1554-1560
CrossRef264
Paul J. Failla, Kevin D. Reed, Warren R. Summer, George H. Karam. (2005) Inferior Vena Caval Filters: Key Considerations. The American Journal of the Medical Sciences 330:2, 82-87
CrossRef265
Sohail K. Mahboobi, Ephron Z. Shohat. (2005) Syncope: An Unusual Presentation of Acute Pulmonary Embolism. Southern Medical Journal 98:8, 845-846
CrossRef266
John R. Kachura. (2005) Inferior Vena Cava Filter Removal after 475-day Implantation. Journal of Vascular and Interventional Radiology 16:8, 1156-1158
CrossRef267
D. IMBERTI, M. BIANCHI, A. FARINA, S. SIRAGUSA, M. SILINGARDI, W. AGENO. (2005) Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. Journal of Thrombosis and Haemostasis 3:7, 1370-1375
CrossRef268
Craig E Daniels, David J Driscoll, Eric S Edell, Mark E Wylam. (2005) Hemoptysis in Proteus Syndrome. Journal of Bronchology 12:3, 171-173
CrossRef269
Paul R Daniels. (2005) Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy. Nature Clinical Practice Urology 2:7, 343-350
CrossRef270
R. D. HULL. (2005) Changes in the technology of inferior vena cava filters promise improved benefits to the patient with less harm, but a paucity of evidence exists. Journal of Thrombosis and Haemostasis 3:7, 1368-1369
CrossRef271
T DELOUGHERY. (2005) Venous Thromboembolism in the ICU and Reversal of Bleeding on Anticoagulants. Critical Care Clinics 21:3, 497-512
CrossRef272
Marcus D'Ayala, Eric T. Nguyen, Jonathan S. Deitch, John B. Degraft-Johnson, Leslie Wise. (2005) Safety of Contrast Venography prior to Caval Interruption in Patients with Renal Insufficiency. Annals of Vascular Surgery 19:3, 347-351
CrossRef273
Marzia Leacche, Daniel Unic, Samuel Z. Goldhaber, James D. Rawn, Sary F. Aranki, Gregory S. Couper, Tomislav Mihaljevic, Robert J. Rizzo, Lawrence H. Cohn, Lishan Aklog, John G. Byrne. (2005) Modern surgical treatment of massive pulmonary embolism: Results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. The Journal of Thoracic and Cardiovascular Surgery 129:5, 1018-1023
CrossRef274
Peter Rosenberger, Stanton K. Shernan, James D. Rawn, Joseph Scott, Holger K. Eltzschig. (2005) Critical Role of Inferior Vena Caval Filter Placement After Pulmonary Embolectomy. Journal of Cardiac Surgery 20:3, 289-290
CrossRef275
Alain F. Le Blanche, Catherine Marteau, Sorina Sime-Bohus, Eric Pautas, Jean-Yves Beinis, François Piette, Pascal Chaibi. (2005) NEW BASES FOR PERCUTANEOUS CAVAL FILTER PLACEMENT ON SITE IN GERIATRIC INSTITUTION IN PATIENTS AGED 75 AND OLDER. Journal of the American Geriatrics Society 53:5, 913-914
CrossRef276
Peter W. Groeneveld, Sara B. Laufer, Alan M. Garber. (2005) Technology Diffusion, Hospital Variation, and Racial Disparities Among Elderly Medicare Beneficiaries. Medical Care 43:4, 320-329
CrossRef277
Steven F. Millward, Clement J. Grassi, Thomas B. Kinney, Sanjoy Kundu, Gary J. Becker, John F. Cardella, Louis G. Martin, James E. Silberzweig, David Sacks. (2005) Reporting Standards for Inferior Vena Caval Filter Placement and Patient Follow-up: Supplement for Temporary and Retrievable/Optional Filters. Journal of Vascular and Interventional Radiology 16:4, 441-443
CrossRef278
Kivilcim Yavuz, Serdar Geyik, Robert E. Barton, John A. Kaufman. (2005) Retrieval of a Malpositioned Vena Cava Filter with Embolic Protection with Use of a Second Filter. Journal of Vascular and Interventional Radiology 16:4, 531-534
CrossRef279
Gregg Elliott, Scott Stevens. (2005) Temporary vena caval interruption and thrombolysis in the management of deep vein thrombosis. Current Treatment Options in Cardiovascular Medicine 7:2, 149-158
CrossRef280
Paul A Kyrle, Sabine Eichinger. (2005) Deep vein thrombosis. The Lancet 365:9465, 1163-1174
CrossRef281
M CORRIERE, M PASSMAN, R GUZMAN, J DATTILO, T NASLUND. (2005) Comparison of Bedside Transabdominal Duplex Ultrasound versus Contrast Venography for Inferior Vena Cava Filter Placement: What Is the Best Imaging Modality?. Annals of Vascular Surgery 19:2, 229-234
CrossRef282
Christoph A. Binkert, Anu Bansal, Jonathan D. Gates. (2005) Inferior Vena Cava Filter Removal after 317-day Implantation. Journal of Vascular and Interventional Radiology 16:3, 395-398
CrossRef283
Agnes Y. Y. Lee. (2005) Management of thrombosis in cancer: primary prevention and secondary prophylaxis. British Journal of Haematology 128:3, 291-302
CrossRef284
Joseph Cherian, Elie Gertner. (2005) Recurrent Pulmonary Embolism Despite Inferior Vena Cava Filter Placement in Patients With the Antiphospholipid Syndrome. JCR: Journal of Clinical Rheumatology 11:1, 56-58
CrossRef285
Daniel Most, Jeffrey Kozlow, Jennifer Heller, Michele A. Shermak. (2005) Thromboembolism in Plastic Surgery. Plastic and Reconstructive Surgery 115:2, 20e-30e
CrossRef286
Eran Hayeems. (2005) IVC Filters: Permanent and Optional Considerations. Journal of Vascular and Interventional Radiology 16:2, P155-P157
CrossRef287
Masahito Sakuma, Mashio Nakamura, Norifumi Nakanishi, Yoshiyuki Miyahara, Nobuhiro Tanabe, Norikazu Yamada, Takayuki Kuriyama, Takeyoshi Kunieda, Tsuneaki Sugimoto, Takeshi Nakano, Kunio Shirato. (2005) Clinical Characteristics, Diagnosis and Management of Patients With Pulmonary Thromboembolism Who are Not Diagnosed in the Acute Phase and Not Classified as Chronic Thromboembolic Pulmonary Hypertension. Circulation Journal 69:9, 1009-1015
CrossRef288
Darlene J. Elias. (2004) Pulmonary Embolism in Orthopaedic Patients: Diagnosis and Treatment. Techniques in Orthopaedics 19:4, 317-326
CrossRef289
Larry Junck. (2004) Supportive management in neuro-oncology: opportunities for patient care, teaching, and research. Current Opinion in Neurology 17:6, 649-653
CrossRef290
James Edwin Muntz. (2004) Treatment of Venous Thromboembolism in Orthopaedic Surgery. Techniques in Orthopaedics 19:4, 337-346
CrossRef291
Leoncio L. Kaw, Ralph B. Dilley. (2004) Use of Vena Cava Filters. Techniques in Orthopaedics 19:4, 327-336
CrossRef292
Alok A Khorana, Robert L Fine. (2004) Pancreatic cancer and thromboembolic disease. The Lancet Oncology 5:11, 655-663
CrossRef293
Olaf Alfons Terhaar, Stuart Macalister Lyon, Mark Frank Given, Anne Elizabeth Foster, Frank Mc Grath, Michael J. Lee. (2004) Extended Interval for Retrieval of Günther Tulip Filters. Journal of Vascular and Interventional Radiology 15:11, 1257-1262
CrossRef294
Carlo J van Dongen, Angelique GM van den Belt, Martin H Prins, AWA Lensing, Martin H Prins. 2004. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. .
CrossRef295
Michael K. Rosner, Timothy R. Kuklo, Rabih Tawk, Ross Moquin, Stephen L. Ondra. (2004) Prophylactic placement of an inferior vena cava filter in high-risk patients undergoing spinal reconstruction. Neurosurgical FOCUS 17:4, 1-6
CrossRef296
Dheeraj K. Rajan, Kenneth W. Sniderman, Barry B. Rubin. (2004) Retrieval of the Bard Recovery Filter from the Superior Vena Cava. Journal of Vascular and Interventional Radiology 15:10, 1169-1171
CrossRef297
Anil Vachani, Selim M. Arcasoy. (2004) Thrombolytic Therapy for Deep Venous Thrombosis. Clinical Pulmonary Medicine 11:5, 328-334
CrossRef298
Bates, Shannon M., Ginsberg, Jeffrey S., . (2004) Treatment of Deep-Vein Thrombosis. New England Journal of Medicine 351:3, 268-277
Full Text299
Fabian Spöhr, Georg C Rehmert, Bernd W Böttiger, Siegfried Hagl, André Gries. (2004) Successful thrombolysis after pulmonary embolectomy for persistent massive postoperative pulmonary embolism. Resuscitation 62:1, 113-118
CrossRef300
Narendra Nathoo, Steven A Toms, Gene H Barnett. (2004) Metastases to the brain: current management perspectives. Expert Review of Neurotherapeutics 4:4, 633-640
CrossRef301
John A. Kaufman. (2004) Re: Metastatic Involvement of a Retrieved Inferior Vena Cava Filter. Journal of Vascular and Interventional Radiology 15:7, 775
CrossRef302
Miguel Angel De Gregorio, María José Gimeno, Fernando Lostalé, Pablo Iñigo, María Consuelo Artigas, Américo Viloria, Eduardo Ramón Alfonso, Horacio D'Agostino. (2004) Retrievability of Uncoated Versus Paclitaxel-coated Günther-Tulip IVC Filters in an Animal Model. Journal of Vascular and Interventional Radiology 15:7, 719-726
CrossRef303
Daniel Farray, Teresa L Carman, Bernardo B Fernandez. (2004) The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases. Neurologic Clinics 22:2, 423-439
CrossRef304
Samuel Z Goldhaber. (2004) Pulmonary embolism. The Lancet 363:9417, 1295-1305
CrossRef305
Shuwei Gao, Carmen Escalante. (2004) Venous thromboembolism and malignancy. Expert Review of Anticancer Therapy 4:2, 303-320
CrossRef306
Jim A. Reekers, Yvonne L. Hoogeveen, Marcel Wijnands, Gjalt Bosma, Rudy Mulder, Vincent L. Oliva. (2004) Evaluation of the Retrievability of the OptEase IVC Filter in an Animal Model. Journal of Vascular and Interventional Radiology 15:3, 261-267
CrossRef307
Steven F. Millward. (2004) Buy Time! Temporary Filter. Journal of Vascular and Interventional Radiology 15:2, P51-P53
CrossRef308
Thomas B. Kinney. (2004) Case Presentation: Post Op Day 3, Chest Pain and Dsypnea. Journal of Vascular and Interventional Radiology 15:2, P44-P50
CrossRef309
Akiko Yagi, Noboru Oriuchi, Noriko Sato, Jun Aoki, Tetsuya Higuchi, Keigo Endo. (2004) Pulmonary Thromboembolism. Circulation Journal 68:6, 599-601
CrossRef310
Masahito Sakuma, Mashio Nakamura, Norifumi Nakanishi, Yoshiyuki Miyahara, Nobuhiro Tanabe, Norikazu Yamada, Takayuki Kuriyama, Takeyoshi Kunieda, Tsuneaki Sugimoto, Takeshi Nakano, Kunio Shirato. (2004) Inferior Vena Cava Filter is a New Additional Therapeutic Option to Reduce Mortality From Acute Pulmonary Embolism. Circulation Journal 68:9, 816-821
CrossRef311
Henry Eriksson. (2004) Treatment of Venous Thromboembolism and Long-Term Prevention of Recurrence. Drugs 64:Supplement 1, 37-46
CrossRef312
M. W. Rich. (2004) The Management of Venous Thromboembolic Disease in Older Adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:1, M34-M41
CrossRef313
Agnes YY Lee. (2003) Anti-thrombotic therapy in cancer patients. Expert Opinion on Pharmacotherapy 4:12, 2213-2220
CrossRef314
Eli V. Gelfand, Gregory Piazza, Samuel Z. Goldhaber. (2003) Venous Thromboembolism Guidebook, Fourth Edition. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 2:4, 247-265
CrossRef315
Z NEEMAN, A AUERBACH, B WOOD. (2003) Metastatic Involvement of a Retrieved Inferior Vena Cava Filter. Journal of Vascular and Interventional Radiology 14:12, 1585-1585
CrossRef316
Juan I Arcelus, Joseph A Caprini, Manuel Monreal, Carmen Suárez, José González-Fajardo. (2003) The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. Journal of Vascular Surgery 38:5, 916-922
CrossRef317
Marcelo P.V Gomes, Karen L Kaplan, Steven R Deitcher. (2003) Patients with inferior vena caval filters should receive chronic thromboprophylaxis. Medical Clinics of North America 87:6, 1189-1203
CrossRef318
Miguel Angel de Gregorio, Pablo Gamboa, María José Gimeno, Blanca Madariaga, Ricardo Tobío, Marcos Herrera, Joaquín Medrano, Antonio Mainar, Ramón Alfonso. (2003) The Günther Tulip Retrievable Filter: Prolonged Temporary Filtration by Repositioning within the Inferior Vena Cava. Journal of Vascular and Interventional Radiology 14:10, 1259-1265
CrossRef319
Agnes Y.Y. Lee. (2003) The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients. Current Opinion in Pulmonary Medicine 9:5, 351-355
CrossRef320
Joel G. Ray. (2003) Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment. Current Opinion in Pulmonary Medicine 9:5, 378-384
CrossRef321
(2003) Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up. Journal of Vascular and Interventional Radiology 14:9, S427-S432
CrossRef322
Anaadriana Zakarija, Hau C Kwaan. (2003) Bleeding and thrombosis in the cancer patient. Expert Review of Cardiovascular Therapy 1:2, 271-281
CrossRef323
A. K. Chan, G. Deveber, P. Monagle, L. A. Brooker, P. M. Massicotte. (2003) Venous thrombosis in children. Journal of Thrombosis and Haemostasis 1:7, 1443-1455
CrossRef324
M. N. Levine, A. Y. Lee, A. K. Kakkar. (2003) From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. Journal of Thrombosis and Haemostasis 1:7, 1456-1463
CrossRef325
Mark N. Levine. (2003) Can we optimise treatment of thrombosis?. Cancer Treatment Reviews 29, 19-22
CrossRef326
Elias N. Brountzos, John A. Kaufman, Anthony C. Venbrux, P. Rand Brown, Jason Harry, Thomas F. Kinst, Stephen Kleshinski, Adrian C. Ravenscroft. (2003) A New Optional Vena Cava Filter: Retrieval at 12 Weeks in an Animal Model. Journal of Vascular and Interventional Radiology 14:6, 763-772
CrossRef327
Elchanan Bruckheimer, Alon G. Judelman, Simon D. Bruckheimer, Isaac Tavori, Gil Naor, Barry T. Katzen. (2003) In Vitro Evaluation of a Retrievable Low-Profile Nitinol Vena Cava Filter. Journal of Vascular and Interventional Radiology 14:4, 469-474
CrossRef328
Thomas B. Kinney. (2003) Update on Inferior Vena Cava Filters. Journal of Vascular and Interventional Radiology 14:4, 425-440
CrossRef329
Clive Kearon. (2003) Duration of therapy for acute venous thromboembolism. Clinics in Chest Medicine 24:1, 63-72
CrossRef330
Selim M Arcasoy, Anil Vachani. (2003) Local and systemic thrombolytic therapy for acute venous thromboembolism. Clinics in Chest Medicine 24:1, 73-91
CrossRef331
Roger D Yusen, Brian F Gage. (2003) Outpatient treatment of acute venous thromboembolic disease. Clinics in Chest Medicine 24:1, 49-61
CrossRef332
Rodger L Bick, Sylvia Haas. (2003) Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patients. Hematology/Oncology Clinics of North America 17:1, 217-258
CrossRef333
Steven F. Millward. (2003) The Gunter Tulip Filter. Journal of Vascular and Interventional Radiology 14:2, P237-P239
CrossRef334
Murray Asch. (2003) The Recovery Filter. Journal of Vascular and Interventional Radiology 14:2, P239-P244
CrossRef335
Timothy D Girard, John T Philbrick, J Fritz Angle, Daniel M Becker. (2003) Prophylactic vena cava filters for trauma patients: a systematic review of the literature. Thrombosis Research 112:5-6, 261-267
CrossRef336
Peter Kaboli, Mark C Henderson, Richard H White. (2003) DVT prophylaxis and anticoagulation in the surgical patient. Medical Clinics of North America 87:1, 77-110
CrossRef337
Philip C Comp. (2003) Treatment and management of acute venous thromboembolic disease. Thrombosis Research 111:1-2, 3-8
CrossRef338
Tetsuya Ishikawa, Teruo Okabe, Kazuo Ogawa, Jun Fuse, Yoko Oshiba, Akira Ono, Masao Chino. (2003) Usefulness of a Second Temporary Vena Cava Filter for Preventing Acute Pulmonary Thromboembolism. Circulation Journal 67:8, 718-720
CrossRef339
Teresa L. Carman, Andrew A. Kanner, Gene H. Barnett, Steven R. Deitcher. (2003) Prevention of Thromboembolism after Neurosurgery for Brain and Spinal Tumors. Southern Medical Journal 96:1, 17-22
CrossRef340
Douglas E. Sutherland, Ilene C. Weitz, Howard A. Liebman. (2003) Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment. American Journal of Hematology 72:1, 43-52
CrossRef341
Mizuhiro Arima, Tatsuji Kanoh, Atsutoshi Takagi, Kosei Tanimoto, Tetsuya Oigawa, Shigeru Matsuda. (2003) Clinical Features of Acute Pulmonary Thromboembolism in Younger Patients. Circulation Journal 67:4, 330-333
CrossRef342
K.S. DESHPANDE, C. HATEM, M. KARWA, H. ULRICH, T.K. ALDRICH, V. KVETAN. (2002) The use of inferior vena cava filter as a treatment modality for massive pulmonary embolism. A case series and review of pathophysiology. Respiratory Medicine 96:12, 984-989
CrossRef343
M LEWISCAREY, S KEE, J FEINSTEIN. (2002) Temporary IVC Filtration before Patent Foramen Ovale Closure in a Patient with Paradoxic Embolism. Journal of Vascular and Interventional Radiology 13:12, 1275-1278
CrossRef344
Joel G Ray. (2002) Why might statins prevent venous thromboembolism: what needs to be done to know more?. Expert Opinion on Investigational Drugs 11:11, 1659-1668
CrossRef345
K. T. Tan, E. J. R. van Beek. (2002) Diagnosis and Treatment of Pulmonary Embolism: An Overview. Imaging Decisions MRI 6:3, 3-10
CrossRef346
Franklin A Michota, Shaun D Frost. (2002) Perioperative management of the hospitalized patient. Medical Clinics of North America 86:4, 731-748
CrossRef347
RODERICK NAZARIO, LAWRENCE J. DELORENZO, GEORGE P. MAGUIRE. (2002) Treatment of Venous Thromboembolism. Cardiology in Review 10:4, 249-259
CrossRef348
Steven R. Deitcher, Teresa L. Carman. (2002) Deep venous thrombosis and pulmonary embolism. Current Treatment Options in Cardiovascular Medicine 4:3, 223-238
CrossRef349
Mark N Levine. (2002) Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer. Cancer Treatment Reviews 28:3, 145-149
CrossRef350
Patrick Y. Wen, Peter W. Marks. (2002) Medical management of patients with brain tumors. Current Opinion in Oncology 14:3, 299-307
CrossRef351
Mark D. Cipolle, Randolph Wojcik, Elizabeth Seislove, Thomas E. Wasser, Michael D. Pasquale. (2002) The Role of Surveillance Duplex Scanning in Preventing Venous Thromboembolism in Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care 52:3, 453-462
CrossRef352
Patrick Nana-Sinkam, Carolyn H. Welsh. (2002) Pulmonary Embolism: Diagnosis and Treatment. Primary Care Case Reviews 5:1, 28-39
CrossRef353
Eduardo G. Calderon, Sarwat Khawar, Jennifer A. Cunningham, Lori D. Russell, Martin A. Alpert. (2002) Pulmonary Artery Thrombus and Subcapsular Liver Hematoma in a Patient with HELLP Syndrome:. The American Journal of the Medical Sciences 323:3, 151-154
CrossRef354
Eli V. Gelfand, Gregory Piazza, Samuel Z. Goldhaber. (2002) Venous Thromboembolism Guidebook. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 1:1, 26-43
CrossRef355
Agnes Y. Y. Lee, Jack Hirsh. (2002) D
IAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM . Annual Review of Medicine 53:1, 15-33
CrossRef356
David Bergqvist. (2002) Enoxaparin. PharmacoEconomics 20:4, 225-243
CrossRef357
M.M. Samama, M.H. Horellou, J. Conard, A. Achkar, I. Elalamy. (2002) Le traitement de la thrombose veineuse profonde par les héparines de bas poids moléculaire. Commentaires sur les recommandations du Consensus Nord-Américain. Annales de Cardiologie et d'Angéiologie 51:3, 172-176
CrossRef358
V.J. Marder. (2001) Thrombolytic therapy: 2001. Blood Reviews 15:3, 143-157
CrossRef359
Andrew F. Shorr, Anthony S. Ramage. (2001) Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications. Critical Care Medicine 29:9, 1659-1665
CrossRef360
Peter F. Fedullo, William R. Auger, Richard N. Channick, Kim M. Kerr, Lewis J. Rubin. (2001) CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. Clinics in Chest Medicine 22:3, 561-581
CrossRef361
David J. Hak. (2001) Prevention of venous thromboembolism in trauma and long bone fractures. Current Opinion in Pulmonary Medicine 7:5, 338-343
CrossRef362
S MILLWARD, V OLIVA, S BELL, D VALENTI, P RASULI, M ASCH, A HADZIOMEROVIC, J KACHURA. (2001) Günther Tulip Retrievable Vena Cava Filter: Results from the Registry of the Canadian Interventional Radiology Association. Journal of Vascular and Interventional Radiology 12:9, 1053-1058
CrossRef363
J. M. Cupitt. (2001) Prophylaxis against thromboembolism in patients with traumatic brain injury: a survey of UK practice. Anaesthesia 56:8, 777-798
CrossRef364
M DESANCHO, J RAND. (2001) BLEEDING AND THROMBOTIC COMPLICATIONS IN CRITICALLY ILL PATIENTS WITH CANCER. Critical Care Clinics 17:3, 599-622
CrossRef365
S PASTORES. (2001) ACUTE RESPIRATORY FAILURE IN CRITICALLY ILL PATIENTS WITH CANCERDiagnosis and Management. Critical Care Clinics 17:3, 623-646
CrossRef366
Samuel Z. Goldhaber. (2001) Prophylaxis of venous thrombosis. Current Treatment Options in Cardiovascular Medicine 3:3, 225-235
CrossRef367
Agnes Y.Y Lee. (2001) Treatment of Venous Thromboembolism in Cancer Patients. Thrombosis Research 102:6, V195-V208
CrossRef368
J.-M. Schleich, O. Morla, M. Laurent, B. Langella, J. Chaperon, C. Almange. (2001) Long-term Follow-up of Percutaneous Vena Cava Filters: a Prospective Study in 100 Consecutive Patients. European Journal of Vascular and Endovascular Surgery 21:5, 450-457
CrossRef369
William G. Kussmaul, Roberto Secaira, Daniel J. McCormick, Marc Cohen. (2001) Right heart catheterization in the presence of an inferior vena cava filter. Catheterization and Cardiovascular Interventions 52:4, 476-478
CrossRef370
Peter F. Fedullo, Douglas M. Humber. (2001) Acute and chronic pulmonary emboli. Current Treatment Options in Cardiovascular Medicine 3:2, 139-150
CrossRef371
Alexander T Cohen, Htwe M Zaw, Raza Alikhan. (2001) Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial. Seminars in Hematology 38, 31-38
CrossRef372
Giancarlo Agnelli, Cecilia Becattini. (2001) Clinical and economic aspects of managing venous thromboembolism in the outpatient setting. Seminars in Hematology 38, 58-66
CrossRef373
Alexander G.G Turpie. (2001) Looking forward in the treatment of deep-vein thrombosis. Seminars in Hematology 38, 49-57
CrossRef374
H ROUSSEAU, P PERREAULT, P OTAL, L STOCKX, J GOLZARIAN, V OLIVA, P REYNAUD, F RAAT, F SZATMARI, G SANTORO. (2001) The 6-F Nitinol TrapEase Inferior Vena Cava Filter: Results of a Prospective Multicenter Trial. Journal of Vascular and Interventional Radiology 12:3, 299-304
CrossRef375
David Schiff. (2001) Single brain metastasis. Current Treatment Options in Neurology 3:1, 89-99
CrossRef376
Mashio NAKAMURA. (2001) Japanese Journal of Thrombosis and Hemostasis 12:6, 450-459
CrossRef377
Maxence Delomez, Jean-Paul Beregi, Serge Willoteaux, Jean-Jacques Bauchart, Bertrand Janne d’Othée, Philippe Asseman, Nessim Perez, Claude Théry. (2001) Mechanical thrombectomy in patients with deep venous thrombosis. Cardiovascular and Interventional Radiology 24:1, 42-48
CrossRef378
John A. Kaufman. (2001) Update on Caval Filtration. Journal of Vascular and Interventional Radiology 12:1, P114-P117
CrossRef379
Lazar J Greenfield, Mary C Proctor. (2000) The percutaneous Greenfield filter: Outcomes and practice patterns. Journal of Vascular Surgery 32:5, 888-893
CrossRef380
Randolph Wojcik, Mark D. Cipolle, Ivy Fearen, James Jaffe, James Newcomb, and Michael D. Pasquale. (2000) Long-Term Follow-Up of Trauma Patients with a Vena Caval Filter. The Journal of Trauma: Injury, Infection, and Critical Care 49:5, 839-843
CrossRef381
Jeroen F van der Heijden, Martin H Prins, Harry R Büller. (2000) For the Initial Treatment of Venous Thromboembolism. Thrombosis Research 100:2, 121-130
CrossRef382
Francis Couturaud, Clive Kearon. (2000) Long-term treatment for venous thromboembolism. Current Opinion in Hematology 7:5, 302-308
CrossRef383
Shih-Tai Hsin, Hsiang-Ning Luk, Su-Man Lin, Kwok-Han Chan, Mei-Yung Tsou, Tak-Yu Lee. (2000) Detection of iatrogenic cardiac tamponade by transesophageal echocardiography during vena cava filter procedure. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 47:7, 638-641
CrossRef384
Deborah L. Ornstein, Leo R. Zacharski. (2000) Cancer, thrombosis, and anticoagulants. Current Opinion in Pulmonary Medicine 6:4, 301-308
CrossRef385
Brigitte Tardy-Poncet, Bernard Tardy. (2000) Heparin-Induced Thrombocytopenia. Drugs & Aging 16:5, 351-364
CrossRef386
Thomas W Wakefield. (2000) Treatment options for venous thrombosis. Journal of Vascular Surgery 31:3, 613-620
CrossRef387
Carlos A. Estrada, Christopher J. Mansfield, Gustavo R. Heudebert. (2000) Cost-effectiveness of Low-Molecular-Weight Heparin in the Treatment of Proximal Deep Vein Thrombosis. Journal of General Internal Medicine 15:2, 108-115
CrossRef388
Philippe Girard, Bernard Tardy, Hervé Decousus. (2000) Inferior Vena Cava Interruption: How and When?. Annual Review of Medicine 51:1, 1-15
CrossRef389
Robert D. Bona, Amy D. Hickey, Donna M. Wallace. (2000) Warfarin Is Safe as Secondary Prophylaxis in Patients With Cancer and a Previous Episode of Venous Thrombosis. American Journal of Clinical Oncology: Cancer Clinical Trials 23:1, 71-73
CrossRef390
Yoshinobu Kanda, Rie Yamamoto, Aki Chizuka, Miyuki Suguro, Tamae Hamaki, Tomohiro Matsuyama, Naoki Takezako, Akiyoshi Miwa, Atsushi Togawa, Masato Kume, Masaaki Tsukuda, Kanehiro Hasuo. (2000) Treatment of Deep Vein Thrombosis Using Temporary Vena Caval Filters after Allogeneic Bone Marrow Transplantation. Leukemia & Lymphoma 38:3-4, 429-433
CrossRef391
Geno J. Merli. (2000) Prophylaxis for deep venous thrombosis and pulmonary embolism in the surgical patient. Clinical Cornerstone 2:4, 15-25
CrossRef392
Walter Ageno. (2000) Treatment of Venous Thromboembolism. Thrombosis Research 97:1, V63-V72
CrossRef393
S MILLWARD, A BHARGAVA, J AQUINOJR, R PETERSON, J VEINOT, J BORMANIS, P WELLS. (2000) Günther Tulip Filter: Preliminary Clinical Experience with Retrieval. Journal of Vascular and Interventional Radiology 11:1, 75-82
CrossRef394
H LORCH, D WELGER, V WAGNER, B HILLNER, E STRECKER, H HERRMANN, G VOSHAGE, C ZUR, C SCHWARZBACH, J SCHRODER. (2000) Current Practice of Temporary Vena Cava Filter Insertion: A Multicenter Registry. Journal of Vascular and Interventional Radiology 11:1, 83-88
CrossRef395
John Blebea, Ryan Wilson, Peter Waybill, Marsha M. Neumyer, Judy S. Blebea, Karla M. Anderson, Robert G. Atnip. (1999) Deep venous thrombosis after percutaneous insertion of vena caval filters. Journal of Vascular Surgery 30:5, 821-829
CrossRef396
A NICHOLSON. (1999) Long-term follow-up of the bird's nest IVC filter. Clinical Radiology 54:11, 759-764
CrossRef397
AGM van den Belt, MH Prins, AWA Lensing, AA Castro, OAC Clark, AN Atallah, E Burihan. 1999. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. .
CrossRef398
Stavros Konstantinides. (1999) Aktuelle Diagnostik und Therapie der akuten Lungenembolie. Herz 24:6, 411-420
CrossRef399
Addison L McMurtry, John T Owings, John T Anderson, Felix D Battistella, Robert Gosselin. (1999) Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. Journal of the American College of Surgeons 189:3, 314-320
CrossRef400
Paolo Prandoni, Pier Mannuccio Mannucci. (1999) Deep-vein thrombosis of the lower limbs: diagnosis and management. Best Practice & Research Clinical Haematology 12:3, 533-554
CrossRef401
L GREENFIELD, R RUTHERFORD. (1999) Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up
. Journal of Vascular and Interventional Radiology 10:8, 1013-1019
CrossRef402
M SIMON. (1999) Vena Cava Filters: Prevalent Misconceptions
CrossRef403
Geno J. Merli. (1999) DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM PROPHYLAXIS IN JOINT REPLACEMENT SURGERY. Rheumatic Disease Clinics of North America 25:3, 639-656
CrossRef404
Gary E. Raskob. (1999) Heparin and low molecular weight heparin for treatment of acute pulmonary embolism. Current Opinion in Pulmonary Medicine 5:4, 216
CrossRef405
Hazzaa Al-Zahrani, Shannon M. Bates, Jeffrey I. Weitz. (1999) Deep vein thrombosis. Current Treatment Options in Cardiovascular Medicine 1:1, 43-53
CrossRef406
S Millward. (1999) Use of an IVC filter in the management of IVC thrombosis. Clinical Radiology 54:3, 198
CrossRef407
Anthonie WA Lensing, Paolo Prandoni, Martin H Prins, HR Büller. (1999) Deep-vein thrombosis. The Lancet 353:9151, 479-485
CrossRef408
G. Chad Hughes, Tony P. Smith, Soumitra R. Eachempati, Steven N. Vaslef, R. Lawrence Reed. (1999) The Use of a Temporary Vena Caval Interruption Device in High-Risk Trauma Patients Unable to Receive Standard Venous Thromboembolism Prophylaxis. The Journal of Trauma: Injury, Infection, and Critical Care 46:2, 246-249
CrossRef409
Gregory A. Schmidt. (1999) Pulmonary embolism. Current Opinion in Critical Care 5:1, 61
CrossRef410
Max P. Rosen. (1999) Spiral CT angiography for suspected pulmonary embolism: A cost-effectiveness analysis. Academic Radiology 6:1, 72-74
CrossRef411
James H Thomas, Kelley M Cornell, Edward L Siegel, Charisse Sparks, Stanton J Rosenthal. (1998) Vena caval occlusion after bird’s nest filter placement. The American Journal of Surgery 176:6, 598-600
CrossRef412
Werner Streif, Maureen E. Andrew. (1998) VENOUS THROMBOEMBOLIC EVENTS IN PEDIATRIC PATIENTS. Hematology/Oncology Clinics of North America 12:6, 1283-1312
CrossRef413
(1998) Pulmonary Embolism. New England Journal of Medicine 339:21, 1555-1557
Full Text414
Daniel M. Ihnat, Joseph L. Mills, John D. Hughes, Andrew T. Gentile, Scott S. Berman, Alex Westerband. (1998) Treatment of patients with venous thromboembolism and malignant disease: Should vena cava filter placement be routine?. Journal of Vascular Surgery 28:5, 800-807
CrossRef415
J H Ryu, E J Olson, P A Pellikka. (1998) Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases.. Mayo Clinic Proceedings 73:9, 873-879
CrossRef416
Goldhaber, Samuel Z., . (1998) Pulmonary Embolism. New England Journal of Medicine 339:2, 93-104
Full Text417
(1998) Vena Caval Filters for the Prevention of Pulmonary Embolism. New England Journal of Medicine 339:1, 46-48
Full Text418
Yu, David R., Miller, Redonda, Bray, Paul F., . (1998) Through Thick and Thin. New England Journal of Medicine 338:23, 1684-1687
Full Text419
Haire, William D., . (1998) Vena Caval Filters for the Prevention of Pulmonary Embolism. New England Journal of Medicine 338:7, 463-464
Full Text
- Letters
